0001213900-23-090587 | S-1/A | XBRL Viewer

Print Document View Excel Document

Commitments and Contingencies (Details) - Schedule of Supplemental Balance Sheet	Sep. 30, 2023	Dec. 31, 2022
Condensed Balance Sheet Statements, Captions [Line Items]
Weighted-average remaining lease term (in years)	1 year 6 months 18 days	2 years 3 months 18 days
Weighted-average discount rate	7.25%	7.25%

Accounting Policies, by Policy (Policies)

6 Months Ended

9 Months Ended

12 Months Ended

Jun. 30, 2023

Sep. 30, 2023

Dec. 31, 2022

Accounting Policies, by Policy (Policies) [Line Items]

Basis of Presentation

Basis of Presentation

The accounting and reporting policies of the Company conform to GAAP. The Company’s fiscal year is December 31.

Basis of Presentation

The accounting and reporting policies of the Company conform to accounting principles generally accepted in the United States of America (“GAAP”). The Company’s fiscal year is December 31.

Reverse Merger and Recapitalization

Reverse Merger and Recapitalization

On July 31, 2023, the board of directors of Patricia Acquisition Corp., a Delaware corporation (“Patricia”) and all of its pre-Merger stockholders approved a restated certificate of incorporation, which was effective upon its filing with the Secretary of State of the State of Delaware on July 31, 2023, and through which Patricia changed its name to “Serve Robotics Inc.”

On July 31, 2023, Patricia’s wholly-owned subsidiary, Serve Acquisition Corp., a corporation formed in the State of Delaware on July 10, 2023 (“Acquisition Sub”), merged with and into Serve Robotics Inc. (“Serve”). Pursuant to this transaction (the “Merger”), Serve was the surviving corporation and became our wholly owned subsidiary, and all of the outstanding stock of Serve was converted into shares of our common stock. All of Serve’s outstanding warrants, options and stock appreciation rights were assumed by us. Following the consummation of the Merger, Serve changed its name to “Serve Operating Co.”

The Merger is being accounted for as a reverse-merger and recapitalization. Serve is the acquirer for financial reporting purposes, and Patricia is the acquired company under the acquisition method of accounting in accordance with FASB ASC Topic 805, Business Combinations. Consequently, the assets, liabilities and operations that will be reflected in the historical financial statements prior to the Merger will be those of Serve and will be recorded at the historical cost basis of Serve, and the consolidated financial statements after completion of the Merger will include the assets, liabilities and results of operations of Serve up to the day prior to the closing of the Merger and the assets, liabilities and results of operations of the combined company from and after the closing date of the Merger.

As a result of the Merger, each of Serve’s shares of capital stock issued and outstanding immediately prior to the closing of the Merger was converted into the right to receive 0.8035 shares of Patricia’s common stock (the “Common Share Conversion Ratio”). Accordingly, all share and per share amounts for all periods presented in the accompanying consolidated financial statements and notes thereto have been adjusted retroactively, where applicable, to reflect the Common Share Conversion Ratio and the par value of Patricia, $0.0001 per share.

The authorized shares of preferred and common stock in the accompanying consolidated balance sheets reflect the historical authorized shares of Serve. Upon the Merger, there were 10,000,000 authorized shares of preferred stock and 300,000,000 shares of common stock.

Unaudited Pro Forma Financial Information

Unaudited Pro Forma Financial Information

At the Closing of the Merger described above, all outstanding shares of the Series Seed Preferred Stock were converted into shares of common stock.

The unaudited pro-forma balance sheet information as of December 31, 2022 has been prepared to give effect to the exchange of all 7,987,195 outstanding shares of the various Series Seed Preferred Stock, converted into an equal number of common stock as if the exchange had occurred on December 31, 2022. The shares of common stock issuable and the proceeds expected to be received in the Business Combination are excluded from such pro-forma financial information.

	December 31, 2022
	Actual			Pro Forma
Stockholders’ deficit:				(unaudited)
Series Seed preferred stock	$	309		$	-
Series Seed-1 preferred stock		244			-
Series Seed-2 preferred stock		209			-
Series Seed-3 preferred stock		36			-
Common stock		683			1,481
Additional paid-in capital		31,232,737			31,232,737
Subscription receivable		(165,719	)		(165,719	)
Accumulated deficit		(43,520,645	)		(43,520,645	)
Total stockholders’ deficit	$	(12,452,146	)	$	(12,452,146	)

Principles of Consolidation

Principles of Consolidation

These condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Serve Operating Co. and Serve Robotics Canada Inc. All inter-company transactions and balances have been eliminated on consolidation.

Principles of Consolidation

These consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary Serve Robotics Canada Inc. All inter-company transactions and balances have been eliminated on consolidation.

Use of Estimates

Use of Estimates

The preparation of the Company’s consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant estimates and assumptions reflected in these financial statements include, but are not limited to, valuation of future equity obligations and stock-based compensation. The Company bases its estimates on historical experience, known trends and other market-specific or other relevant factors that it believes to be reasonable under the circumstances. On an ongoing basis, management evaluates its estimates when there are changes in circumstances, facts and experience. Changes in estimates are recorded in the period in which they become known. Actual results could differ from those estimates.

Use of Estimates

The preparation of the Company’s financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant estimates and assumptions reflected in these financial statements include, but are not limited to, the valuations of common stock and options. The Company bases its estimates on historical experience, known trends and other market-specific or other relevant factors that it believes to be reasonable under the circumstances. On an ongoing basis, management evaluates its estimates when there are changes in circumstances, facts and experience. Changes in estimates are recorded in the period in which they become known. Actual results could differ from those estimates.

Concentrations of Credit Risk

Concentrations of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents. The Company generally maintains balances in various operating accounts at financial institutions that management believes to be of high credit quality, in amounts that may exceed federally insured limits. The Company has not experienced any losses related to its cash and cash equivalents and does not believe that it is subject to unusual credit risk beyond the normal credit risk associated with commercial banking relationships. As of September 30, 2023 and December 31, 2022, the Company’s cash and cash equivalents were held at one accredited financial institution. As of September 30, 2023 and December 31, 2022, the Company had balances in excess of insured amounts, respectively.

Concentrations of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents. The Company generally maintains balances in various operating accounts at financial institutions that management believes to be of high credit quality, in amounts that may exceed federally insured limits. The Company has not experienced any losses related to its cash and cash equivalents and does not believe that it is subject to unusual credit risk beyond the normal credit risk associated with commercial banking relationships. At December 31, 2022 and 2021, all of the Company’s cash and cash equivalents were held at one accredited financial institution. As of December 31, 2022 and 2021, the Company had $2,465,719 and $7,715,861, respectively, in excess of insured amounts.

Cash and Cash Equivalents

Cash and Cash Equivalents

The Company considers all highly liquid investments with maturities of three months or less at the date of purchase to be cash equivalents.

Cash and Cash Equivalents

The Company considers all highly liquid investments with maturities of three months or less at the date of purchase to be cash equivalents.

Fair Value Measurements

Fair Value Measurements

Certain assets and liabilities of the Company are carried at fair value under GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. Financial assets and liabilities carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable:

●

Level 1—Quoted prices in active markets for identical assets or liabilities.

●

Level 2—Observable inputs (other than Level 1 quoted prices), such as quoted prices in active markets for similar assets or liabilities, quoted prices in markets that are not active for identical or similar assets or liabilities, or other inputs that are observable or can be corroborated by observable market data.

●

Level 3—Unobservable inputs that are supported by little or no market activity that are significant to determining the fair value of the assets or liabilities, including pricing models, discounted cash flow methodologies and similar techniques.

The carrying values of the Company’s accounts receivable, prepaid expenses and accounts payable and accrued expenses approximate their fair values due to the short-term nature of these assets and liabilities.

See Notes 4 and 7 for fair value disclosures of future equity obligations.

Fair Value Measurements

●

Level 1—Quoted prices in active markets for identical assets or liabilities.

●

The carrying values of the Company’s assets and liabilities approximate their fair values.

See Note 4 for fair value measurement disclosures.

Accounts Receivable

Accounts Receivable

Accounts receivable are derived from services delivered to customers and are stated at their net realizable value. The Company accounts for allowance for doubtful accounts under ASC 310-10-35. Each month, the Company reviews its receivables on a customer-by-customer basis and evaluates whether an allowance for doubtful accounts is necessary based on any known or perceived collection issues. Any balances that are eventually deemed uncollectible are written off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. As of September 30, 2023 and December 31, 2022, the Company determined there was no allowance for doubtful accounts necessary.

Accounts Receivable

Accounts receivable are derived from products and services delivered to customers and are stated at their net realizable value. Each month, the Company reviews its receivables on a customer-by-customer basis and evaluates whether an allowance for doubtful accounts is necessary based on any known or perceived collection issues. Any balances that are eventually deemed uncollectible are written off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote.

Inventory

Inventory

Inventory is stated at the lower of cost or market value and accounted for using the specific identification cost method. As of September 30, 2023 and December 31, 2022, inventory primarily consists of robotic component parts from the Company’s suppliers. Management reviews its inventory for obsolescence and impairment annually and did not record a reserve for obsolete inventory for the nine months ended September 30, 2023 and 2022.

Inventory

Inventory is stated at the lower of cost or market value and accounted for using the specific identification cost method. As of December 31, 2022 and 2021, inventory primarily consists of robotic component parts from the Company’s suppliers. Management reviews its inventory for obsolescence and impairment annually and did not record a reserve for obsolete inventory for the years ended December 31, 2022 and 2021.

Property and Equipment

Property and Equipment

Property and equipment are stated at cost less accumulated depreciation. Depreciation expense is recognized using the straight-line method over the estimated useful life of the asset, which is three (3) to five (5) years for office equipment and two (2) years for the Company’s robot assets. Estimated useful lives are periodically assessed to determine if changes are appropriate. Maintenance and repairs are charged to expense as incurred. When assets are retired or otherwise disposed of, the cost of these assets and related accumulated depreciation or amortization are eliminated from the balance sheets and any resulting gains or losses are included in the statement of operations in the period of disposal. (See Note 5).

Property and Equipment

Property and equipment are stated at cost less accumulated depreciation. Depreciation expense is recognized using the straight-line method over the estimated useful life of the asset, which is three (3) to five (5) years for office equipment and two (2) years for the Company’s current robot assets. Estimated useful lives are periodically assessed to determine if changes are appropriate. Maintenance and repairs are charged to expense as incurred. When assets are retired or otherwise disposed of, the cost of these assets and related accumulated depreciation or amortization are eliminated from the balance sheets and any resulting gains or losses are included in the statement of operations in the period of disposal.

Impairment of Long-Lived Assets

Impairment of Long-Lived Assets

The Company accounts for long-lived assets in accordance with the provisions of ASC 360-10-35, Property, Plant and Equipment, Impairment or Disposal of Long-lived Assets. The Company continually monitors events and changes in circumstances that could indicate carrying amounts of long-lived assets may not be recoverable. When such events or changes in circumstances are present, the Company assesses the recoverability of long-lived assets by determining whether the carrying value of such assets will be recovered through undiscounted expected future cash flows. If the total of the future cash flows is less than the carrying amount of those assets, the Company recognizes an impairment loss based on the excess of the carrying amount over the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or the fair value less costs to sell.

Impairment of Long-Lived Assets

The Company continually monitors events and changes in circumstances that could indicate carrying amounts of long-lived assets may not be recoverable. When such events or changes in circumstances are present, the Company assesses the recoverability of long-lived assets by determining whether the carrying value of such assets will be recovered through undiscounted expected future cash flows. If the total of the future cash flows is less than the carrying amount of those assets, the Company recognizes an impairment loss based on the excess of the carrying amount over the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or the fair value less costs to sell.

Revenue Recognition

Revenue Recognition

The Company accounts for revenue under ASC 606, Revenue from Contracts with Customers. The Company determines revenue recognition through the following steps:

	●	Identification of a contract with a customer;

	●	Identification of the performance obligations in the contract;

	●	Determination of the transaction price;

	●	Allocation of the transaction price to the performance obligations in the contract; and

●

Recognition of revenue when or as the performance obligations are satisfied.

Revenue is recognized when control of the promised goods or services is transferred to customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. As a practical expedient, the Company does not adjust the transaction price for the effects of a significant financing component if, at contract inception, the period between customer payment and the transfer of goods or services is expected to be one year or less.

To date, the Company has generated initial revenues from its delivery services as well as branding fees. For delivery services, the Company satisfies its performance obligation when the delivery is complete, which is the point in time control of the delivered product transfers to the customer. The Company recognizes branding fees over time as performance obligations are completed over the term of the agreement.

During the nine months ended September 30, 2023, delivery revenue was $111,784, branding fees were $45,250 and other revenue was $7,792, respectively. During the nine months ended September 30, 2022, delivery revenue was $35,049 and branding fees were $25,640, respectively.

Revenue Recognition

The Company accounts for revenue in accordance with ASC 606 – Revenue from Contracts with Customers ( “ASC 606”). The Company determines revenue recognition through the following steps:

	●	Identification of a contract with a customer;

	●	Identification of the performance obligations in the contract;

	●	Determination of the transaction price;

	●	Allocation of the transaction price to the performance obligations in the contract; and

●

Recognition of revenue when or as the performance obligations are satisfied.

During the year ended December 31, 2022, delivery revenue was $54,423 and branding fees were $53,575, respectively.

Cost of Revenue

Cost of Revenue

Cost of revenue consists primarily of allocations of depreciation on robot assets used for revenue producing activities, personnel time related to revenue activities, and costs related to data, software and similar costs that allow the robots to function as intended and for the Company to communicate with the robots while in service.

Cost of Revenue

Sales and Marketing

Sales and Marketing

Sales and marketing expenses include personnel costs and public relations expenses. Advertising costs are expensed as incurred and included in sales and marketing expenses. Advertising expense were approximately $0 and $47,700 for the three months ended September 30, 2023 and 2022, and $184,000, and $144,000 for the nine months ended September 30, 2023 and 2022, all respectively.

Sales and Marketing

Sales and marketing expenses includes personnel costs and public relations expenses. Advertising costs are expensed as incurred and included in sales and marketing expense.

Operations

Operations

Operations expenses primarily consists of costs for field operations personnel that support operations in cities, including supervisors and related costs.

General and Administrative Expenses

General and Administrative Expenses

General and administrative expenses primarily consist of personnel-related expenses for executive management and administrative functions, including finance and accounting, legal, and human resources, as well as general corporate expenses and general insurance. General and administrative expenses also include depreciation on property and equipment as well as amortization of right of use assets. These costs are expensed as incurred.

General and Administrative Expenses

General and administrative expenses primarily consist of personnel-related expenses for executive management and administrative functions, including finance and accounting, legal, and human resources, as well as general corporate expenses and general insurance. General and administrative expenses also include depreciation on certain property and equipment as well as amortization of allocated portions of right of use assets. These costs are expensed as incurred.

Research and Development Costs

Research and Development Costs

Costs incurred in the research and development of the Company’s products are expensed as incurred. Research and development costs include product design, hardware and software costs.

Research and Development Costs

Costs incurred in the research and development of the Company’s products are expensed as incurred. Research and development costs include product design, hardware and software costs.

Concentrations

Concentrations

During the nine months ended September 30, 2023, one customer accounted for 68% of revenue.

Concentrations

The Company is dependent on third-party vendors to supply inventory and products for research and development activities and parts for building products. In particular, the Company relies and expects to continue to rely on a small number of vendors. The loss of one of these vendors may have a negative short-term impact on the Company’s operations; however, the Company believes there are acceptable substitute vendors that can be utilized longer-term.

Accounting for Preferred Stock

Accounting for Preferred Stock

ASC 480, Distinguishing Liabilities from Equity, includes standards for how an issuer of equity (including equity shares issued by consolidated entities) classifies and measures on its consolidated balance sheet certain financial instruments with characteristics of both liabilities and equity.

Management is required to determine the presentation for the preferred stock as a result of the redemption and conversion provisions, among other provisions in the agreement. Specifically, management is required to determine whether the embedded conversion feature in the preferred stock is clearly and closely related to the host instrument, and whether the bifurcation of the conversion feature is required and whether the conversion feature should be accounted for as a derivative instrument. If the host instrument and conversion feature are determined to be clearly and closely related (both more akin to equity), derivative liability accounting under ASC 815, Derivatives and Hedging, is not required. Management determined that the host contract of the preferred stock is more akin to equity, and accordingly, liability accounting is not required by the Company. The Company has presented preferred stock within stockholders’ equity.

Costs incurred directly for the issuance of the preferred stock are recorded as a reduction of gross proceeds received by the Company, resulting in a discount to the preferred stock. The discount is not amortized.

Stock-Based Compensation

Stock-Based Compensation

The Company accounts for stock-based compensation in accordance with ASC 718, Compensation - Stock Compensation. The Company measures all stock-based awards granted to employees, directors and non-employee consultants based on the fair value on the date of the grant and recognizes compensation expense for those awards over the requisite service period, which is generally the vesting period of the respective award. For awards with service-based vesting conditions, the Company records the expense for using the straight-line method. For awards with performance-based vesting conditions, the Company records the expense if and when the Company concludes that it is probable that the performance condition will be achieved.

The Company classifies stock-based compensation expense in its statement of operations in the same manner in which the award recipient’s payroll costs are classified or in which the award recipient’s service payments are classified.

The fair value of each stock option grant is estimated on the date of grant using the Black-Scholes option-pricing model. The Company historically has been a private company and lacks company-specific historical and implied volatility information for its stock. Therefore, it estimates its expected stock price volatility based on the historical volatility of publicly traded peer companies and expects to continue to do so until such time as it has adequate historical data regarding the volatility of its own traded stock price. The expected term of the Company’s stock options has been determined utilizing the “simplified” method for awards that qualify as “plain-vanilla” options. The risk-free interest rate is determined by reference to the U.S. Treasury yield curve in effect at the time of grant of the award for time periods approximately equal to the expected term of the award. Expected dividend yield is based on the fact that the Company has never paid cash dividends on common stock and does not expect to pay any cash dividends in the foreseeable future. Forfeitures are recognized as incurred. Determining the appropriate fair value of stock-based awards requires the input of subjective assumptions. The assumptions used in calculating the fair value of stock-based awards represent management’s best estimates and involve inherent uncertainties and the application of management’s judgment. As a result, if factors change and management uses different assumptions, stock-based compensation expense could be materially different for future awards.

Leases

Leases

In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) 2016 02, Leases (ASC 842). This ASU requires a lessee to recognize a right-of-use asset and a lease liability under most operating leases in its balance sheet. The ASU is effective for annual and interim periods beginning after December 15, 2021. Early adoption is permitted. The Company adopted ASC 842 on January 1, 2022 using the modified retrospective approach. The Company elected the package of practical expedients available for existing contracts, which allowed the Company to carry forward our historical assessments of lease identification, lease classification, and initial direct costs and did not require retrospective medication. The Company also elected a policy to not apply the recognition requirements of ASC 842 for short-term leases with a term of 12 months or less.

The Company determines if an arrangement is a lease, or includes an embedded lease, at inception for each contract or agreement. A contract is or contains an embedded lease if the contract meets all of the below criteria:

(i)

there is an identified asset

(ii)

the Company obtains substantially all of the economic benefits of the asset

(iii)

the Company has the right to direct the use of the asset

The Company’s operating lease agreements include office and warehouse space. ROU assets represent the right to use an underlying asset for the lease term and operating lease liabilities represent the obligation to make payments arising from the lease or embedded lease. Operating lease ROU assets and operating lease liabilities are recognized at commencement date based on the present value of the future minimum lease payments over the lease term. As most leases do not provide an implicit rate, the Company uses an incremental borrowing rate that is based on the estimated rate of interest for a collateralized borrowing of a similar asset, using a similar term as the lease payments at the commencement date. Indirect capital costs are capitalized and included in the ROU assets at commencement.

The operating lease ROU assets and operating lease liabilities include any lease payments made, including any variable amounts that are based on an index or rate, and exclude lease incentives. Variability that is not due to an index or rate, such as payments made based on hourly rates, are excluded from the lease liability. Lease terms may include options to extend or terminate the lease.

Renewal option periods are included within the lease term and the associated payments are recognized in the measurement of the operating ROU asset and operating lease liability when they are at our discretion and considered reasonably certain of being exercised. Over the lease term, the Company uses the effective interest rate method to account for the lease liability as lease payments are made and the ROU asset is amortized in a manner that results in straight-line expense recognition. (See Note 10).

Leases

In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) 2016 02, Leases (ASC 842). This ASU requires a lessee to recognize a right-of-use asset and a lease liability under most operating leases in its balance sheet. The ASU is effective for annual and interim periods beginning after December 15, 2021. Early adoption is permitted. The Company adopted ASC 842 on January 1, 2022 using the modified retrospective approach. The Company elected the package of practical expedients available for existing contracts, which allowed the Company to carry forward our historical assessments of lease identification, lease classification, and initial direct costs. The Company also elected a policy to not apply the recognition requirements of ASC 842 for short-term leases with a term of 12 months or less.

(i)

there is an identified asset

(ii)

the Company obtains substantially all of the economic benefits of the asset

(iii)

the Company has the right to direct the use of the asset

Income Taxes

Income Taxes

The Company uses the liability method of accounting for income taxes as set forth in ASC 740, Income Taxes. Under the liability method, deferred taxes are determined based on the temporary differences between the financial statement and tax basis of assets and liabilities using tax rates expected to be in effect during the years in which the basis differences reverse. A valuation allowance is recorded when it is unlikely that the deferred tax assets will not be realized. We assess our income tax positions and record tax benefits for all years subject to examination based upon our evaluation of the facts, circumstances and information available at the reporting date. In accordance with ASC 740-10, for those tax positions where there is a greater than 50% likelihood that a tax benefit will be sustained, the Company’s policy will be to record the largest amount of tax benefit that is more likely than not to be realized upon ultimate settlement with a taxing authority that has full knowledge of all relevant information. For those income tax positions where there is less than 50% likelihood that a tax benefit will be sustained, no tax benefit will be recognized in the financial statements.

Net Loss per Common Share

Net Loss per Share

Net earnings or loss per share is computed by dividing net income or loss by the weighted-average number of common shares outstanding during the period, excluding shares subject to redemption or forfeiture. The Company presents basic and diluted net earnings or loss per share. Diluted net earnings or loss per share reflect the actual weighted average of common shares issued and outstanding during the period, adjusted for potentially dilutive securities outstanding. Potentially dilutive securities are excluded from the computation of the diluted net loss per share if their inclusion would be anti-dilutive. As all potentially dilutive securities are anti-dilutive as of September 30, 2023 and December 31, 2022, diluted net loss per share is the same as basic net loss per share for each period. Potentially dilutive items outstanding as of September 30, 2023 and 2022 is as follows:

	September 30,
	2023		2022
Series Seed preferred stock (convertible to common stock)		-		3,091,672
Series Seed-1 preferred stock (convertible to common stock)		-		2,440,412
Series Seed-2 preferred stock (convertible to common stock)		-		2,088,696
Series Seed-3 preferred stock (convertible to common stock)		-		357,836
Common stock warrants		142,730		54,203
Preferred stock warrants		-		128,819
Stock options		1,594,800		941,406
Unvested restricted common stock issued not outstanding		326,839		-
Total potentially dilutive shares		2,064,369		9,103,044

Excluded in the table of September 30, 2022 are the number of shares that would be issuable upon the conversion of Simple Agreements for Future Equity, for which the number of shares are indeterminable as of September 30, 2022. Upon consummation of the Merger, all outstanding SAFEs were converted into 4,372,601 shares of common stock (see Notes 4, 7 and 8).

Upon the Merger, all outstanding shares of preferred stock were converted into an aggregate of 7,978,616 shares of common stock. Furthermore, all outstanding warrants to purchase shares of Series Seed preferred stock were converted into 128,819 warrants to purchase shares of common stock.

Net Loss per Share

Net earnings or loss per share is computed by dividing net income or loss by the weighted-average number of common shares outstanding during the period, excluding shares subject to redemption or forfeiture. The Company presents basic and diluted net earnings or loss per share. Diluted net earnings or loss per share reflect the actual weighted average of common shares issued and outstanding during the period, adjusted for potentially dilutive securities outstanding. Potentially dilutive securities are excluded from the computation of the diluted net loss per share if their inclusion would be anti-dilutive. As all potentially dilutive securities are anti-dilutive as of December 31, 2022 and 2021, diluted net loss per share is the same as basic net loss per share for each period. Potentially dilutive items outstanding as of December 31, 2022 and 2021 is as follows:

	December 31,
	2022		2021
Series Seed preferred stock (convertible to common stock)		3,091,672		2,834,033
Series Seed-1 preferred stock (convertible to common stock)		2,440,411		2,440,411
Series Seed-2 preferred stock (convertible to common stock)		2,088,696		2,088,696
Series Seed-3 preferred stock (convertible to common stock)		357,836		357,836
Common stock warrants		54,203		13,912
Preferred stock warrants		128,819		128,819
Stock options		861,309		590,073
Total potentially dilutive shares		9,022,946		8,453,780

Excluded in the table below are the number of shares that would be issuable upon the conversion of Simple Agreements for Future Equity, for which the number of shares are indeterminable. The table also excludes 417,301 shares of restricted stock considered issued but not outstanding due to vesting requirements (Note 8).

Recently Issued Accounting Pronouncements

Recently Adopted Accounting Pronouncements

Management does not believe that any other recently issued, but not yet effective, accounting standards could have a material effect on the accompanying financial statements. As new accounting pronouncements are issued, the Company will adopt those that are applicable under the circumstances.

Recently Adopted Accounting Pronouncements

Management does not believe that any other recently issued, but not yet effective, accounting standards could have a material effect on the accompanying consolidated financial statements. As new accounting pronouncements are issued, the Company will adopt those that are applicable under the circumstances.

Capital Stock Conversion

Capital Stock Conversion

In addition to the above, the par value of the Company after the Merger was changed to $0.0001 per share. Accordingly, all par value amounts for all periods presented in the accompanying consolidated financial statements and notes thereto have been adjusted retroactively, where applicable, to reflect the par value adjustment.

Unaudited Interim Financial Information

Unaudited Interim Financial Information

The unaudited interim condensed financial statements and related notes have been prepared in accordance with GAAP for interim financial information, within the rules and regulations of the United States Securities and Exchange Commission (the “SEC”). Certain information and disclosures normally included in the annual consolidated financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. The unaudited interim financial statements have been prepared on a basis consistent with the audited financial statements and in the opinion of management, reflect all adjustments, consisting of only normal recurring adjustments, necessary for the fair presentation of the results for the interim periods presented and of the financial condition as of the date of the interim balance sheet. The financial data and the other information disclosed in these notes to the interim financial statements related to the nine-month periods are unaudited. Unaudited interim results are not necessarily indicative of the results for the full fiscal year.

The accompanying unaudited interim condensed financial statements should be read in conjunction with the Company’s audited financial statements and the notes thereto for the year ended December 31, 2022 included in the Form 8-K filed with the SEC on August 4, 2023.

Deferred Offering Costs

Deferred Offering Costs

The Company complies with the requirements of FASB ASC 340-10-S99-1 with regards to offering costs. Prior to the completion of an offering, offering costs are capitalized. The deferred offering costs are charged to additional paid-in capital or as a discount to debt, as applicable, upon the completion of an offering or to expense if the offering is not completed. As of September 30, 2023, there were no deferred offering costs.

Convertible Instruments

Convertible Instruments

GAAP requires companies to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. An exception to this rule is when the host instrument is deemed to be conventional as that term is described under applicable GAAP.

Subscription Receivable

Subscription Receivable

The Company records stock issuances at the effective date. If the subscription is not funded upon issuance, the Company records an escrow receivable as an asset on a balance sheet. When subscription receivables are not received prior to the issuance of financial statements at a reporting date in satisfaction of the requirements under FASB ASC 505-10-45-2, the subscription is reclassified as a contra account to stockholders’ equity on the consolidated balance sheet.

Operations

Operations

Operations expenses primarily consist of costs for field operations personnel.

Patricia Acquisition Corp.[Member]

Accounting Policies, by Policy (Policies) [Line Items]

Basis of Presentation

The accompanying unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the Securities and Exchange Commission (the “SEC.”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a compete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

Basis of Presentation

The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”).

Use of Estimates

The preparation of the condensed financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates.

Income Taxes

The Company accounts for income taxes under ASC 740, “Income Taxes”, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets, including tax loss and credit carry-forwards, and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Deferred income tax expense represents the change during the period in the deferred tax assets and deferred tax liabilities. The components of the deferred tax assets and liabilities are individually classified as current and non-current based on their characteristics. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.

The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of June 30, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

Income Taxes

The Company adopted ASC 740, “Income Taxes”, at its inception. Under ASC 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets, including tax loss and credit carry-forwards, and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The components of the deferred tax assets and liabilities are individually classified as current and non-current based on their characteristics. Deferred income tax expense represents the change during the period in the deferred tax assets and deferred tax liabilities. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.

The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2022 and 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

Net Loss per Common Share

Net loss per share is computed by dividing net loss by the weighted average number of common shares outstanding for the period. Diluted earnings per share takes into effect any dilutive instruments, except when doing so would be anti-dilutive. As of June 30, 2023 and 2022, there were no dilutive instruments.

Net Loss per Common Share

Net loss per share is computed by dividing net loss by the weighted average number of common shares outstanding for the period. Diluted earnings per share takes into effect any dilutive instruments, except when doing so would be anti-dilutive. As of December 31, 2022 and 2021, there were no dilutive instruments.

Recently Issued Accounting Pronouncements

Management does not believe that any recently issued, but not yet effective accounting pronouncements, if adopted, would have a material effect on the accompanying financial statements.

Recently Issued Accounting Pronouncements

Management does not believe that any recently issued, but not yet effective accounting pronouncements, if adopted, would have a material effect on the accompanying financial statements.

Emerging Growth Company

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012, or the “JOBS Act”. As such, the Company is eligible to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not “emerging growth companies” including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in the Company’s periodic reports and proxy statements, and exemptions from the requirements of holding a non-binding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. If some investors find the securities less attractive as a result, there may be a less active trading market for securities and the prices of securities may be more volatile.

In addition, Section 107 of the JOBS Act also provides that an “emerging growth company” can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards (that is, an “emerging growth company” can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies). The Company intends to take advantage of the benefits of this extended transition period.

Additionally, the Company is a “smaller reporting company” as defined in Item 10(f)(1) of Regulation S-K. Smaller reporting companies may take advantage of certain reduced disclosure obligations, including, among other things, providing only two years of audited financial statements. The Company will remain a smaller reporting company until the last day of the fiscal year in which (1) the market value of the ordinary shares held by non-affiliates equals or exceeds $250 million as of the prior June 30, and (2) the annual revenues equaled or exceeded $100 million during such completed fiscal year or the market value of the ordinary shares held by non-affiliates equals or exceeds $700 million as of the prior June 30.

Emerging Growth Company

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012, or the JOBS Act. As such, the Company is eligible to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not “emerging growth companies” including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in the Company’s periodic reports and proxy statements, and exemptions from the requirements of holding a non-binding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. If some investors find the securities less attractive as a result, there may be a less active trading market for securities and the prices of securities may be more volatile.

Commitments and Contingencies (Details) - USD ($)		1 Months Ended	9 Months Ended	12 Months Ended
Commitments and Contingencies (Details) - USD ($)	Oct. 31, 2024	Nov. 30, 2022	Sep. 30, 2023	Dec. 31, 2022	Dec. 31, 2023
Commitments and Contingencies (Details) [Line Items]
Proceeds received		$ 3,561,288
Repayment of company			$ 1,658,359
Outstanding liability			$ 2,418,969
Original equipment cost			40.00%
Forecast [Member]
Commitments and Contingencies (Details) [Line Items]
Agreement monthly payment	$ 189,262
Security deposit	378,524
Purchase amount					$ 2,300,000
Previously Reported [Member]
Commitments and Contingencies (Details) [Line Items]
Proceeds received		$ 4,455,852
Repayment of company				$ 378,524
Interim payments				544,422
Outstanding liability				$ 4,077,328
Original equipment cost				40.00%
Previously Reported [Member] \| Forecast [Member]
Commitments and Contingencies (Details) [Line Items]
Agreement monthly payment	189,262
Security deposit	$ 378,524
Purchase amount					$ 2,300,000

Summary of Significant Accounting Policies (Details) - Schedule of Basic and Diluted Net Loss Per Share - shares	9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021
Summary of Significant Accounting Policies (Details) - Schedule of Basic and Diluted Net Loss Per Share [Line Items]
Total potentially dilutive shares	2,064,369	9,103,044	9,022,946	8,453,780
Series Seed Preferred Stock [Member]
Summary of Significant Accounting Policies (Details) - Schedule of Basic and Diluted Net Loss Per Share [Line Items]
Total potentially dilutive shares		3,091,672	3,091,672	2,834,033
Series Seed-1 Preferred Stock [Member]
Summary of Significant Accounting Policies (Details) - Schedule of Basic and Diluted Net Loss Per Share [Line Items]
Total potentially dilutive shares		2,440,412	2,440,411	2,440,411
Series Seed-2 Preferred Stock [Member]
Summary of Significant Accounting Policies (Details) - Schedule of Basic and Diluted Net Loss Per Share [Line Items]
Total potentially dilutive shares		2,088,696	2,088,696	2,088,696
Series Seed-3 Preferred Stock [Member]
Summary of Significant Accounting Policies (Details) - Schedule of Basic and Diluted Net Loss Per Share [Line Items]
Total potentially dilutive shares		357,836	357,836	357,836
Common Stock Warrants [Member]
Summary of Significant Accounting Policies (Details) - Schedule of Basic and Diluted Net Loss Per Share [Line Items]
Total potentially dilutive shares	142,730	54,203	54,203	13,912
Preferred Stock Warrants [Member]
Summary of Significant Accounting Policies (Details) - Schedule of Basic and Diluted Net Loss Per Share [Line Items]
Total potentially dilutive shares		128,819	128,819	128,819
Stock Options [Member]
Summary of Significant Accounting Policies (Details) - Schedule of Basic and Diluted Net Loss Per Share [Line Items]
Total potentially dilutive shares	1,594,800	941,406	861,309	590,073
Unvested Restricted Common Stock Issued Not Outstanding [Member]
Summary of Significant Accounting Policies (Details) - Schedule of Basic and Diluted Net Loss Per Share [Line Items]
Total potentially dilutive shares	326,839

Future Equity Obligations

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Future Equity Obligations [Abstract]

FUTURE EQUITY OBLIGATIONS

7. FUTURE EQUITY OBLIGATIONS

In 2023, the Company entered into Simple Agreements for Future Equity (“SAFE”) for aggregate purchase amounts of $2,666,953. The 2023 agreements, which provide the right of the investors to future equity in the Company, are subject to a valuation cap of $65 million. The agreements have a discount rate of 80%.

If there is a preferred equity financing before the termination of the SAFEs, on the initial closing of such equity financing, this SAFE will automatically convert into the number of shares of Safe Preferred Stock equal to the Purchase Amount divided by the Discount Price or Conversion Price. The Discount Price is the price per share of the Standard Preferred Stock sold in the equity financing multiplied by the Discount Rate. The Conversion Price is 1) the Safe Price or (2) the Discount Price, whichever calculation results in a greater number of shares of Safe Preferred Stock. The SAFE price is the price per share equal to the valuation cap divided by the Company’s dilutive shares outstanding.

Upon the Merger in July 2023, all remaining outstanding SAFEs were converted into 4,372,601 shares of common stock.

As of September 30, 2023 and December 31, 2022, the fair value of SAFEs was $0 and $13,150,745, respectively. See Note 4 for fair value disclosures.

7.	FUTURE EQUITY OBLIGATIONS

In 2022 and 2021, the Company entered into Simple Agreements for Future Equity (“SAFE”) for aggregate purchase amounts of $12,885,001 and $7,925,000, respectively. The 2022 agreements, which provide the right of the investors to future equity in the Company, are subject to a valuation cap of $65.0 million for $2,300,000 of the purchase amount with the remaining agreements being uncapped. The agreements have a discount rate of 80%. The 2021 agreements had a valuation cap of $35.0 million.

For the 2022 SAFEs, if there is a preferred equity financing before the termination of the SAFEs, on the initial closing of such equity financing, this SAFE will automatically convert into the number of shares of Safe Preferred Stock equal to the Purchase Amount divided by the Discount Price or Conversion Price. The Discount Price is the price per share of the Standard Preferred Stock sold in the equity financing multiplied by the Discount Rate. The Conversion Price is 1) the Safe Price or (2) the Discount Price, whichever calculation results in a greater number of shares of Safe Preferred Stock. The SAFE price is the price per share equal to the valuation cap divided by the Company’s dilutive shares outstanding.

In October 2021, the Company completed an equity financing of Series Seed preferred stock (see Note8) at a price per share of $3.1187. Upon this financing, all of the outstanding SAFEs then outstanding, automatically converted into Series Seed 1-3 preferred stock. Immediately prior to the conversion, the Company recorded a fair value adjustment to reflect the number of shares that the obligations converted into at the underlying fair value of the Series Seed preferred stock. At conversion, the fair value of the obligations was $18,968,155, which were then converted into (i) 2,440,411 shares of Series Seed-1 preferred stock, (ii) 2,088,696 shares of Series Seed-2 preferred stock, and (iii) 357,836 shares of Series Seed-3 preferred stock.

Fair Value Measurements (Details) - Schedule of Level 3 Liabilities Measured at Fair Value - Simple Agreement For Future Equity [Member] - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Fair Value Measurements (Details) - Schedule of Level 3 Liabilities Measured at Fair Value [Line Items]
Beginning	$ 13,150,745
Issuance of simple agreements for future equity	2,666,953	12,885,001	7,925,000
Change in fair value	1,672,706	265,744	11,043,155
Conversion to Series Seed-1, Seed-2 and Seed-3 preferred stock			(18,968,155)
Ending		$ 13,150,745

Commitments and Contingencies (Details) - Schedule of Future Principal Payments	Dec. 31, 2022 USD ($)
Commitments and Contingencies (Details) - Schedule of Future Principal Payments [Line Items]
2023	$ 2,214,348
2024	1,862,980
Total	$ 4,077,328

Stock-Based Compensation (Details) - Schedule of Information Related to Stock Options - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Schedule of Summary of Information Related to Stock Options [Abstract]
Stock options, Outstanding as of Begining balance	861,309
Weighted Average Exercise Price, Outstanding as of Begining balance	$ 0.49
Intrinsic Value, Outstanding as of Begining balance
Stock options, Granted	765,477
Weighted Average Exercise Price, Granted	$ 0.75
Stock options, Exercised
Weighted Average Exercise Price, Exercised
Stock options, Forfeited	(31,985)
Weighted Average Exercise Price, Forfeited	$ 0.49
Stock options, Outstanding as of Ending balance	1,594,800	861,309
Weighted Average Exercise Price, Outstanding as of Ending balance	$ 0.61	$ 0.49
Intrinsic Value, Outstanding as of Ending balance	$ 5,405,876
Stock options, Exercisable as of balance	296,057	170,125
Weighted Average Exercise Price, Exercisable as of balance	$ 0.51	$ 0.49
Intrinsic Value, Exercisable as of balance	$ 1,292,215

Note Payable

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Note Payable [Abstract]

NOTE PAYABLE

6. NOTE PAYABLE

Silicon Valley Bank

In March 2022, the Company entered into a promissory note with Silicon Valley Bank (“SVB”) for a principal amount of $2,500,000. The note matures on March 1, 2025 and bears interest at the greater of 3.25% or prime rate. The loan had interest-only payments through September 2022, and then requires monthly principal payments of $83,333, plus interest, beginning October 2022. During the nine months ended September 30, 2023, the Company made repayments approximately $750,000 and $1,500,000 remained outstanding. Interest expense was $58,315 for the nine months ended September 30, 2023, all of which was paid. The note is subject to subordination related to leased assets of the Company.

In connection with the note, the Company issued SVB 40,292 warrants to purchase common stock. The warrants have an exercise price of $0.49 per share, are immediately exercisable and have a term of 12 years. The fair value of the warrant was $49,000, which was recognized as a debt discount and will be amortized to interest expense over the life of the note. During the nine months ended September 30, 2023, amortization of debt discount was $12,250. Upon the Merger, all warrants were no longer outstanding.

As of September 30, 2023, note payable, net of unamortized discount of $23,150, was $1,476,850.

Short-Term Notes

Prior to the Merger, the Company received $750,000 in proceeds from short-term notes. The loans accrued interest on the unpaid principal amount at a rate of 18% per annum. Each holder of the notes was entitled to an exit fee equal to 16% of the stated principal amount of such holder’s note, less the total amount of interest that accrued on such note prior to the closing of the Merger (the “Exit Fee”). Upon the Merger, the Company fully repaid the notes and exit fee for a total of $920,015.

Convertible Note Payable

In April 2023, the Company received bridge financing totaling $3,001,500 in principal for which the Company received $2,798,410 in net proceeds (the “April Notes”). As a result, the Company incurred fees of $203,090 which was recorded as a debt discount. The April Notes bore interest at 10% per annum and are payable six months from the date of the bridge financing, subject to conversion. The April Notes were convertible into shares of common stock at a conversion price equal to 80% of the price per the PIPE offering (the “Private Placement”), which initially closed simultaneously with the Merger on July 31, 2023 (see Note 8). Upon the closing of the Merger and the initial closing of the Private Placement, the outstanding principal amount of the Bridge Notes was automatically converted into 937,961 shares of common stock at a conversion price of $3.20 per share. Furthermore, accrued interest on the April Notes were forgiven; therefore, no interest was recognized as of the closing of the Merger.

The Company evaluated the terms of the conversion features of the April Notes as noted above in accordance with ASC Topic No. 815 – 40, Derivatives and Hedging – Contracts in Entity’s Own Stock, and determined they are not indexed to the Company’s common stock and that the conversion feature, which is akin to a redemption feature, meet the definition of a liability. The notes contain an indeterminate number of shares to settle with conversion options outside of the Company’s control. Therefore, the Company bifurcated the conversion feature and accounted for it as a separate derivative liability. Upon issuance of the April Notes, the Company recognized a derivative liability at a fair value of $601,000, which was recorded as a debt discount and was amortized over the life of the notes. Upon the Merger and the Private Placement, the derivative liability had a fair value of $750,000, which was reclassified to additional paid-in capital in connection with the conversion of the underlying notes.

For the nine months ended September 30, 2023, the Company amortized $804,465 of the debt discount to interest expense. At September 30, 2023, the outstanding balance of the April Notes, less unamortized discount of $0, was $0.

In connection with the April Notes, the Company granted each holder warrants to purchase common stock equal to 50% of the number of shares of common stock into which the loan is convertible into at an exercise price of $3.20 per share. Furthermore, the Company granted warrants to the brokers (the “Bridge Brokers”) equal to 8% of the number of shares of common stock into which April Notes, other than those purchased by insider investors, would convert at the closing of the Merger, with an exercise price of $3.20 per share. As the issuance of the warrants noted above were contingent on the closing of the Merger, they were not considered granted until July 31, 2023 (see Note 9).

Note Payable – Related Party

In June and July 2023, the Company issued a senior secured promissory note with its Chief Executive Officer for which the Company received $449,000 in proceeds. The note bore interest at 7.67% per annum and matured upon the Merger.

In connection with this note, the Company agreed to pay an exit fee upon repayment of the note equal to 16% of the principal, less the total interest that accrued until repayment. Upon the Merger, the Company fully repaid the note and exit fee for a total of $520,840.

Patricia – Stockholder

As of the Merger, Patricia had an outstanding note with its then majority stockholder for $151,500. As of September 30, 2023, the balance remained outstanding.

6.	NOTE PAYABLE

In March 2022, the Company entered into a promissory note with Silicon Valley Bank (“SVB”) for a principal amount of $2,500,000. The note matures on March 1, 2025 and bears interest at the greater of 3.25% or prime rate. The loan had interest-only payments through September 2022, and then requires monthly principal payments of $83,333, plus interest, beginning October 2022. Through December 31, 2022, the Company has made principal repayments totaling $250,000 and $2,250,000 remained outstanding. Interest expense was $58,463 for the year ended December 31, 2022, all of which was paid. The note is secured by the Company’s assets, subject to certain and permitted subordination.

In connection with the note, the Company issued SVB 40,292 warrants to purchase common stock. The warrants have an exercise price of $0.49 per share, are immediately exercisable and have a term of 12 years. The fair value of the warrant was $49,000, which was recognized as a debt discount and will be amortized to interest expense over the life of the note. During the year ended December 31, 2022, amortization of debt discount was $13,600.

As of December 31, 2022, note payable, net of unamortized discount of $35,400, was $2,214,600. The following is a summary of future principal payments owed as of December 31, 2022:

Year Ending December 31,
2023	$	1,000,000
2024		1,000,000
2025		250,000
	$	2,250,000

- Definition

The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(c))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 470
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org//470/tableOfContent

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1C
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1C
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1C
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1E
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I

+ Details

Fair Value Measurements (Details) - Schedule of Financial Assets and Liabilities Subject to Fair Value Measurements - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Fair Value Measurements (Details) - Schedule of Financial Assets and Liabilities Subject to Fair Value Measurements [Line Items]
Total		$ 13,150,745
Fair Value, Recurring [Member]
Fair Value Measurements (Details) - Schedule of Financial Assets and Liabilities Subject to Fair Value Measurements [Line Items]
Simple agreement for future equity		13,150,745
Derivative liability
Fair Value, Inputs, Level 1 [Member]
Fair Value Measurements (Details) - Schedule of Financial Assets and Liabilities Subject to Fair Value Measurements [Line Items]
Total
Fair Value, Inputs, Level 1 [Member] \| Fair Value, Recurring [Member]
Fair Value Measurements (Details) - Schedule of Financial Assets and Liabilities Subject to Fair Value Measurements [Line Items]
Simple agreement for future equity
Derivative liability
Total
Fair Value, Inputs, Level 2 [Member]
Fair Value Measurements (Details) - Schedule of Financial Assets and Liabilities Subject to Fair Value Measurements [Line Items]
Total
Fair Value, Inputs, Level 2 [Member] \| Fair Value, Recurring [Member]
Fair Value Measurements (Details) - Schedule of Financial Assets and Liabilities Subject to Fair Value Measurements [Line Items]
Simple agreement for future equity
Derivative liability
Total
Fair Value, Inputs, Level 3 [Member]
Fair Value Measurements (Details) - Schedule of Financial Assets and Liabilities Subject to Fair Value Measurements [Line Items]
Total		13,150,745
Fair Value, Inputs, Level 3 [Member] \| Fair Value, Recurring [Member]
Fair Value Measurements (Details) - Schedule of Financial Assets and Liabilities Subject to Fair Value Measurements [Line Items]
Simple agreement for future equity		13,150,745
Derivative liability
Total		$ 13,150,745

- Definition

Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480524/946-210-50-6

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (a)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480524/946-210-50-6

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (a)(2)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480524/946-210-50-6

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (a)(4)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480524/946-210-50-6

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480524/946-210-50-1

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480524/946-210-50-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480524/946-210-50-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)(2)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480524/946-210-50-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480524/946-210-50-6

Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (a)(3)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480524/946-210-50-6

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-04(9)(e))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 5C
-Subparagraph (SX 210.12-13C(Column H)(Footnote 7))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-04(9)(b))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-04(9)(d))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 5
-Subparagraph (SX 210.12-13(Column G)(Footnote 8))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 5C
-Subparagraph (SX 210.12-13C(Column H))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 5
-Subparagraph (SX 210.12-13(Column G))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 5A
-Subparagraph (SX 210.12-13A(Column E))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5A

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 5B
-Subparagraph (SX 210.12-13B(Column E))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 5B
-Subparagraph (SX 210.12-13B(Column E)(Footnote 4))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483466/210-20-50-3

Reference 22: http://www.xbrl.org/2003/role/exampleRef
-Topic 210
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483444/210-20-55-22

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483444/210-20-55-10

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482907/825-10-50-10

+ Details

Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)	3 Months Ended		6 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2021
Cash flows from operating activities:
Net loss					$ (17,750,350)	$ (14,600,764)	$ (21,855,127)		$ (21,665,518)
Cash flows from financing activities:
Depreciation					1,396,919	40,521	388,139		42,469
Stock-based compensation					304,256	113,806	195,056		8,714
Change in fair value of simple agreements for future equity					1,672,706	(4,506)	265,744		11,043,155
Amortization of debt discount					816,715	9,167	13,600
Warrants issued with convertible note					991,000
Change in fair value of derivative liability	$ 149,000				149,000		265,744		11,043,155
Interest on recourse loan					(2,797)
Changes in operating assets and liabilities:
Accounts receivable					19,742	(30,980)	(23,697)
Inventory					(250,459)	(5,190,776)	(154,840)		(463,422)
Prepaid expenses					(517,233)	(337,276)	(81,339)
Other current assets							11,163		(11,163)
Accounts payable					782,454	2,803,257	(174,278)		336,315
Accrued liabilities					129,481	2,886	37,434
Right of use liabilities, net					(35,782)	210,518	(24,641)
Net cash used in operating activities					(12,294,348)	(16,984,147)	(21,402,786)		(10,709,450)
Cash flows from investing activities:
Purchase of property and equipment					(2,493)	(83,662)	(3,644,950)		(162,085)
Deposits						(389,636)	(416,012)		(96,647)
Net cash used in investing activities					(2,493)	(473,298)	(4,060,962)		(258,732)
Proceeds from simple agreement for future equity					2,666,953	10,585,002	12,885,001		7,925,000
Proceeds from note payable					750,000	2,500,000	2,500,000
Repayments of note payable					(1,500,000)		(250,000)
Proceeds from convertible note payable					2,798,410
Proceeds from note payable, related party					449,000
Repayments of note payable, related party					(449,000)
Proceeds from lease liability financing							4,455,852
Repayment of lease liability financing					(1,658,359)		(378,524)
Issuance of common stock pursuant to Merger, net of offering costs					10,026,258
Issuance of founders’ stock									4,400
Issuance of restricted common stock, net of repurchases							1,278		4,645
Issuance of Series Seed preferred stock						999,999	999,999		10,999,998
Net cash provided by financing activities					13,083,262	14,085,001	20,213,606		18,934,043
Net change in cash and cash equivalents					786,421	(3,372,444)	(5,250,142)		7,965,861
Cash and cash equivalents at beginning of period			$ 2,715,719	$ 7,965,861	2,715,719	7,965,861	7,965,861
Cash and cash equivalents at end of period	3,502,140	4,593,417			3,502,140	4,593,417	2,715,719	$ 7,965,861	7,965,861
Supplemental disclosure of cash flow information:
Cash paid for income taxes
Cash paid for interest					258,256		622,730
Supplemental disclosure of non-cash investing and financing activities:
Restricted stock award liability							162,747
Vested restricted stock purchased with recourse notes					10,302
Derivative liability in connection with convertible note					601,000
Debt discount issued as accrued liability					63,840
Conversion of SAFE into common stock					17,490,404
Conversion of convertible note and derivative into common stock in connection with merger					3,751,875
Warrants issued in connection with note payable						49,000	49,000
Note payable, related party of predecessor assumed in Merger					151,500
Subscription receivable							165,719
Conversion of simple agreement for future equity into preferred stock									18,968,155
Patricia Acquisition Corp.
Cash flows from operating activities:
Net loss			(29,321)	(27,078)			(51,354)	(54,627)
Adjustments to reconcile net loss to net cash used in operating activities:
Accounts payable and accrued expenses			600	2,500			2,500	3,000
Cash flows from financing activities:
Proceeds from note payable - stockholder			37,500	26,980			49,040	42,460
Changes in operating assets and liabilities:
Net cash used in operating activities			(28,721)	(24,578)			(48,854)	(51,627)
Cash flows from investing activities:
Net cash provided by financing activities			37,500	26,980			49,040	42,460
Net change in cash and cash equivalents			8,779	2,402			186	(9,167)
Cash and cash equivalents at beginning of period	$ 9,236	$ 2,673	457	271	$ 457	$ 271	271	9,438
Cash and cash equivalents at end of period			$ 9,236	$ 2,673			$ 457	$ 271	$ 271

Income Taxes

6 Months Ended

12 Months Ended

Jun. 30, 2023

Dec. 31, 2022

Income Taxes [Line Items]

INCOME TAXES

10.

INCOME TAXES

Deferred taxes are recognized for temporary differences between the basis of assets and liabilities for financial statement and income tax purposes. The differences relate solely to net operating loss carryforwards. As of December 31, 2022 and 2021, the Company had net deferred tax assets before valuation allowance of $8,978,639 and $2,982,757, respectively. The following table presents the deferred tax assets and liabilities by source:

	December 31,
	2022			2021
Deferred tax assets:
Net operating loss carryforwards	$	8,940,441		$	2,982,757
Other temporary differences		85,998			-
Valuation allowance		(9,026,439	)		(2,982,757	)
Net deferred tax assets	$	-		$	-

The Company recognizes deferred tax assets to the extent that it believes that these assets are more likely than not to be realized. In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. The Company assessed the need for a valuation allowance against its net deferred tax assets and determined a full valuation allowance is required due to taxable losses for the periods ended 2022 and 2021, cumulative losses through December 31, 2022, and no history of generating taxable income. Therefore, valuation allowances of $9,026,439 and $2,982,757 were recorded as of December 31, 2022 and 2021, respectively. Valuation allowance increased by $6,043,682 and $2,982,757 during the periods ended December 31, 2022 and 2021, respectively. Deferred tax assets were calculated using the Company’s combined effective tax rate, which it estimated to be 28.0%. The effective rate is reduced to 0% due to the full valuation allowance on net deferred tax assets.

The Company’s ability to utilize net operating loss carryforwards will depend on its ability to generate adequate future taxable income. At December 31, 2022 and 2021, the Company had net operating loss carryforwards available to offset future taxable income in the amount of $31,805,199 and $10,611,018, respectively.

The Company has evaluated its income tax positions and has determined that it does not have any uncertain tax positions. The Company will recognize interest and penalties related to any uncertain tax positions through its income tax expense.

The Company may in the future become subject to federal, state and local income taxation though it has not been since its inception, other than minimum state tax. The Company is not presently subject to any income tax audit in any taxing jurisdiction, though its 2021-2022 tax years remain open to examination.

Patricia Acquisition Corp.[Member]

Income Taxes [Line Items]

INCOME TAXES

Note 4. Income Taxes

As of June 30, 2023 and December 31, 2022, the Company has approximately $28,400 and $22,300, respectively, in gross deferred tax assets resulting from net operating loss carry-forwards of $135,000 and $106,000, respectively, available to offset future taxable income through 2041 subject to the change in ownership provisions under IRC 382. A valuation allowance has been recorded to fully offset these deferred tax assets because the Company’s management believes future realization of the related tax benefits is uncertain.

The difference between the tax provision at the statutory federal income tax rate on June 30, 2023 and December 31, 2022, and the tax provisions attributable to loss before income taxes is as follows:

	June 30, 2023			December 31, 2022
Statutory federal income taxes		21.0	%		21.0	%
Valuation allowance		(21.0	)%		(21.0	)%
Effective income tax rate, net		-	%		-	%

Note 4. Income Taxes

As of December 31, 2022 and 2021, the Company has approximately $22,300 and $11,500, respectively, in gross deferred tax assets resulting from net operating loss carry-forwards of $106,000 and $54,600, respectively, available to offset future taxable income through 2041 subject to the change in ownership provisions under IRC 382. A valuation allowance has been recorded to fully offset these deferred tax assets because the Company’s management believes future realization of the related tax benefits is uncertain.

The difference between the tax provision at the statutory federal income tax rate on December 31, 2022 and 2021 and the tax provisions attributable to loss before income taxes is as follows:

	December 31,
	2022			2021
Statutory federal income taxes		21.0	%		21.0	%
Valuation allowance		(21.0	)%		(21.0	)%
Effective income tax rate, net		-			-

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480990/946-20-50-13

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h)(2))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org//740/tableOfContent

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482685/740-10-50-14

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482685/740-10-50-21

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 270
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482526/740-270-50-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 17
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482685/740-10-50-17

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I.5.Q1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 11.C)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479360/740-10-S99-2

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482603/740-30-50-2

+ Details

Summary of Significant Accounting Policies (Details)	3 Months Ended		6 Months Ended	9 Months Ended		12 Months Ended
Summary of Significant Accounting Policies (Details)	Sep. 30, 2023 USD ($) $ / shares shares	Sep. 30, 2022 USD ($)	Jun. 30, 2023 shares	Sep. 30, 2023 USD ($) $ / shares shares	Sep. 30, 2022 USD ($)	Dec. 31, 2022 USD ($) $ / shares shares	Jul. 31, 2023 shares	Feb. 28, 2022 $ / shares	Dec. 31, 2021 USD ($) shares	Oct. 31, 2021 $ / shares
Summary of Significant Accounting Policies (Details) [Line Items]
Conversion ratio				0.8035		0.8035
Par value per share (in Dollars per share) \| $ / shares	$ 0.0001			$ 0.0001		$ 0.0001
Preferred stock shares, authorized (in Shares)	10,000,000			10,000,000		10,000,000
Common stock shares, authorized (in Shares)	300,000,000			300,000,000		300,000,000
Excess of insured amounts \| $						$ 2,465,719			$ 7,715,861
Goods or services expected term						1 year
Delivery revenue \| $				$ 111,784	$ 35,049	$ 54,423
Branding fees \| $				$ 45,250	25,640	$ 53,575
Short-term leases term						12 years
Maximum tax benefit percentage						50.00%
Minimum tax benefit percentage						50.00%
Restricted stock considered issued (in Shares)						417,301
Revenue percentage				68.00%
Other revenue \| $				$ 7,792
Advertising expense \| $	$ 0	$ 47,700		$ 184,000	$ 144,000
(in Shares)				4,372,601
Aggregate shares of common stock (in Shares)	7,978,616			7,978,616			7,978,616
Preferred stock converted into warrants (in Shares)	128,819			128,819
Common Stock [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Common stock shares, authorized (in Shares)						300,000,000
Patricia Acquisition Corp.[Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Preferred stock shares, authorized (in Shares)			10,000,000			10,000,000			10,000,000
Common stock shares, authorized (in Shares)			50,000,000			50,000,000			50,000,000
Smaller reporting company, description			(1) the market value of the ordinary shares held by non-affiliates equals or exceeds $250 million as of the prior June 30, and (2) the annual revenues equaled or exceeded $100 million during such completed fiscal year or the market value of the ordinary shares held by non-affiliates equals or exceeds $700 million as of the prior June 30.			(1) the market value of the ordinary shares held by non-affiliates equals or exceeds $250 million as of the prior June 30, and (2) the annual revenues equaled or exceeded $100 million during such completed fiscal year or the market value of the ordinary shares held by non-affiliates equals or exceeds $700 million as of the prior June 30.
Series Seed Preferred Stock [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Par value per share (in Dollars per share) \| $ / shares								$ 3.8814		$ 3.8814
Preferred stock shares, authorized (in Shares)	0			0		4,008,079
Outstanding shares (in Shares)						7,987,195
Office Equipment [Member] \| Minimum [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Straight-line method over the estimated useful life						3 years
Office Equipment [Member] \| Maximum [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Straight-line method over the estimated useful life						5 years
Current Robot Assets [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Straight-line method over the estimated useful life						2 years

Fair Value Measurements

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Fair Value Measurements [Abstract]

FAIR VALUE MEASUREMENTS

4. FAIR VALUE MEASUREMENTS

The Company’s financial assets and liabilities subject to fair value measurements on a recurring basis and the level of inputs used for such measurements were as follows:

Fair Value Measurements
as of September 30, 2023 Using:

Level 1

Level 2

Level 3

Total

Liabilities:

Simple agreement for future equity

Derivative liability

	Fair Value Measurements as of December 31, 2022 Using:
	Level 1		Level 2		Level 3		Total
Liabilities:
Simple agreement for future equity	$	-	$	-	$	13,150,745	$	13,150,745
	$	-	$	-	$	13,150,745	$	13,150,745

Simple Agreements for Future Equity

The Company measures the simple agreements for future equity at fair value based on significant inputs not observable in the market, which causes it to be classified as a Level 3 measurement within the fair value hierarchy. The valuation of the future equity obligations uses assumptions and estimates the Company believes would be made by a market participant in making the same valuation. The Company assesses these assumptions and estimates on an on-going basis as additional data impacting the assumptions and estimates are obtained. Changes in the fair value of the simple agreements for future equity related to updated assumptions and estimates are recognized within the statements of operations.

The simple agreements for future equity may change significantly as additional data is obtained, impacting the Company’s assumptions regarding probabilities of outcomes used to estimate the fair value of the liability. In evaluating this information, considerable judgment is required to interpret the data used to develop the assumptions and estimates. The estimates of fair value may not be indicative of the amounts that could be realized in a current market exchange. Accordingly, the use of different market assumptions and/or different valuation techniques may have a material effect on the estimated fair value amounts, and such changes could materially impact the Company’s results of operations in future periods.

The Company utilized a probability-weighted average approach based on the estimated market value of the underlying securities and the potential settlement outcomes of the simple agreements for future equity, including a liquidity event or future equity financing as well as other settlement alternatives. Both the market value of the underlying securities and the probability of settlement outcomes include unobservable Level 3 inputs.

As of December 31, 2022, the Company assumed a 85% probability of a liquidity and/or equity financing events as the primary ultimate settlement outcomes of the future equity obligations. Immediately prior to the Merger, the Company revalued the remaining outstanding SAFEs using a 100% probability of an equity financing and $4.00 as the fair value of the underlying common stock (see Note 8). Upon the Merger, the SAFEs converted into 4,372,601 shares of common stock at a fair value of $17,490,404.

Derivative Liability

In connection with the Company’s convertible notes, the Company recorded a derivative liability (see Note 6). The estimated fair value of the derivative liability is recorded using significant unobservable measures and other fair value inputs and is therefore classified as a Level 3 financial instrument.

The fair value of the derivative liability is valued using a probability-weighted scenario analysis utilizing the terms of the notes and assumptions regarding cash settlement or conversion to equity. Immediately prior to the Merger, the Company determined a 100% probability of conversion into equity.

The following table sets forth a summary of changes in the fair value of our Level 3 financial instrument liabilities for the nine months ended September 30, 2023:

	Simple Agreement For			Embedded Derivative
	Future Equity			Liability			Total
Outstanding as of December 31, 2022	$	13,150,745		$	-		$	13,150,745
Issuance of simple agreements for future equity		2,666,953			-			2,666,953
Issuance of embedded derivative liability		-			601,000			601,000
Change in fair value		1,672,706			149,000			1,821,706
Conversion to common stock before APO		(17,490,404	)		(750,000	)		(18,240,404	)
Outstanding as of September 30, 2023	$	-		$	-		$	-

4.	FAIR VALUE MEASUREMENTS

The Company’s financial assets and liabilities subject to fair value measurements on a recurring basis and the level of inputs used for such measurements were as follows:

	Fair Value Measurements as of December 31, 2022 Using:
	Level 1		Level 2		Level 3		Total
Liabilities:
Simple agreement for future equity	$	-	$	-	$	13,150,745	$	-
	$	-	$	-	$	13,150,745	$	-

The Company utilized a probability-weighted average approach based on the estimated market value of the underlying securities and the potential settlement outcomes of the simple agreements for future equity, including a liquidity event or future equity financing as well as other settlement alternatives. Both the market value of the underlying securities and the probability of the settlement outcomes include unobservable Level 3 inputs.

As of December 31, 2022, the Company assumed a 85% probability of a liquidity and/or equity financing events as the primary ultimate settlement outcomes of the future equity obligations As of December 31, 2022, the Company calculated the potential number of shares to be converted based on the agreement terms (see Note 7) and the Company’s respective capitalization as of December 31, 2022. In 2021, the Company determined the fair value of the simple agreements for future equity prior to conversion based on the number of shares that the obligations converted into at the underlying fair value of the Series Seed preferred stock. After conversion in 2021, there were no simple agreements for future equity outstanding as of December 31, 2021.

The following table presents changes in Level 3 liabilities measured at fair value for the periods ended December 31, 2022 and 2021:

	Simple
	Agreement For
	Future Equity
Balance at inception	$	-
Issuance of simple agreements for future equity		7,925,000
Change in fair value		11,043,155
Conversion to Series Seed-1, Seed-2 and Seed-3 preferred stock		(18,968,155	)
Outstanding as of December 31, 2021		-
Issuance of simple agreements for future equity		12,885,001
Change in fair value		265,744
Outstanding as of December 31, 2022	$	13,150,745

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

Property and Equipment, Net (Details) - Schedule of Property and Equipment - USD ($)	Sep. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Property, Plant and Equipment [Line Items]
Total	$ 3,809,528	$ 3,807,035	$ 162,085
Less: accumulated depreciation	(1,827,527)	(430,608)	(42,469)
Property and equipment, net	1,982,001	3,376,427	119,616
Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Total	248,240	245,747	$ 162,085
Robot assets [Member]
Property, Plant and Equipment [Line Items]
Total	$ 3,561,288	$ 3,561,288

Unaudited Condensed Consolidated Statements of Changes in Stockholders’ Equity (Deficit) - USD ($)	Previously Reported Series Seed Preferred Stock	Previously Reported Series Seed-1 Preferred Stock	Previously Reported Series Seed-2 Preferred Stock	Previously Reported Series Seed-3 Preferred Stock	Previously Reported Common Stock	Previously Reported Additional Paid-in Capital	Previously Reported Subscription Receivable	Previously Reported Accumulated Deficit	Previously Reported	Series Seed Preferred Stock	Series Seed-1 Preferred Stock	Series Seed-2 Preferred Stock	Series Seed-3 Preferred Stock	Patricia Acquisition Corp Common Stock	Patricia Acquisition Corp Accumulated Deficit	Patricia Acquisition Corp	Common Stock	Additional Paid-in Capital	Subscription Receivable	Accumulated Deficit	Total
Balances Beginning at Dec. 31, 2020														$ 500	$ (18,062)	$ (17,562)
Balances Beginning (in Shares) at Dec. 31, 2020														5,000,000
Net loss															(54,627)	(54,627)
Balance Ending at Dec. 31, 2021	$ 283	$ 244	$ 209	$ 36	$ 711	$ 29,984,430		$ (21,665,518)	$ 8,320,395	$ 283	$ 244	$ 209	$ 36	$ 500	(72,689)	(72,189)	$ 711	$ 29,984,430		$ (21,665,518)	$ 8,320,395
Balance Ending (in Shares) at Dec. 31, 2021	2,834,033	2,440,411	2,088,696	357,836	7,111,123					2,834,033	2,440,411	2,088,696	357,836	5,000,000			7,111,123
Balances Beginning at Jan. 14, 2021
Issuance of founders’ stock					$ 354	4,046			4,400
Issuance of founders’ stock (in Shares)					3,535,400
Issuance of restricted common stock, net of repurchases					$ 357	4,289			4,646
Issuance of restricted common stock, net of repurchases (in Shares)					3,575,723
Issuance of Series Seed preferred stock	$ 283					10,999,715			10,999,998
Issuance of Series Seed preferred stock (in Shares)	2,834,033
Conversion of SAFEs into preferred stock		$ 244	$ 209	$ 36		18,967,666			18,968,155
Conversion of SAFEs into preferred stock (in Shares)		2,440,411	2,088,696	357,836
Stock-based compensation						8,714			8,714
Net loss								(21,665,518)	(21,665,518)												(21,665,518)
Balance Ending at Dec. 31, 2021	$ 283	$ 244	$ 209	$ 36	$ 711	29,984,430		(21,665,518)	8,320,395	$ 283	$ 244	$ 209	$ 36	$ 500	(72,689)	(72,189)	$ 711	29,984,430		(21,665,518)	8,320,395
Balance Ending (in Shares) at Dec. 31, 2021	2,834,033	2,440,411	2,088,696	357,836	7,111,123					2,834,033	2,440,411	2,088,696	357,836	5,000,000			7,111,123
Issuance of Series Seed preferred stock										$ 26								999,973			999,999
Issuance of Series Seed preferred stock (in Shares)										257,639
Restricted stock awards repurchased																	$ (22)	22
Restricted stock awards repurchased (in Shares)																	(217,588)
Stock-based compensation																		9,026			9,026
Warrants issued in connection with note payable																		49,000			49,000
Net loss															(7,888)	(7,888)				(3,942,145)	(3,942,145)
Balance Ending at Mar. 31, 2022										$ 309	$ 244	$ 209	$ 36	$ 500	(80,577)	(80,077)	$ 689	31,042,452		(25,607,663)	5,436,275
Balance Ending (in Shares) at Mar. 31, 2022										3,091,672	2,440,411	2,088,696	357,836	5,000,000			6,893,535
Balances Beginning at Dec. 31, 2021	$ 283	$ 244	$ 209	$ 36	$ 711	29,984,430		(21,665,518)	8,320,395	$ 283	$ 244	$ 209	$ 36	$ 500	(72,689)	(72,189)	$ 711	29,984,430		(21,665,518)	8,320,395
Balances Beginning (in Shares) at Dec. 31, 2021	2,834,033	2,440,411	2,088,696	357,836	7,111,123					2,834,033	2,440,411	2,088,696	357,836	5,000,000			7,111,123
Net loss																(27,078)
Balance Ending at Jun. 30, 2022										$ 309	$ 244	$ 209	$ 36	$ 500	(99,767)	(99,267)	$ 687	31,053,511		(30,907,678)	147,317
Balance Ending (in Shares) at Jun. 30, 2022										3,091,672	2,440,411	2,088,696	357,836	5,000,000			6,871,977
Balances Beginning at Dec. 31, 2021	$ 283	$ 244	$ 209	$ 36	$ 711	29,984,430		(21,665,518)	8,320,395	$ 283	$ 244	$ 209	$ 36	$ 500	(72,689)	(72,189)	$ 711	29,984,430		(21,665,518)	8,320,395
Balances Beginning (in Shares) at Dec. 31, 2021	2,834,033	2,440,411	2,088,696	357,836	7,111,123					2,834,033	2,440,411	2,088,696	357,836	5,000,000			7,111,123
Net loss																					(14,600,764)
Balance Ending at Sep. 30, 2022										$ 309	$ 244	$ 209	$ 36				$ 687	31,148,051		(36,266,283)	(5,116,747)
Balance Ending (in Shares) at Sep. 30, 2022										3,091,672	2,440,411	2,088,696	357,836				6,870,423
Balances Beginning at Dec. 31, 2021	$ 283	$ 244	$ 209	$ 36	$ 711	29,984,430		(21,665,518)	8,320,395	$ 283	$ 244	$ 209	$ 36	$ 500	(72,689)	(72,189)	$ 711	29,984,430		(21,665,518)	8,320,395
Balances Beginning (in Shares) at Dec. 31, 2021	2,834,033	2,440,411	2,088,696	357,836	7,111,123					2,834,033	2,440,411	2,088,696	357,836	5,000,000			7,111,123
Issuance of Series Seed preferred stock	$ 26					999,973			999,999
Issuance of Series Seed preferred stock (in Shares)	257,639
Restricted stock purchased with recourse notes						4,250	(165,719)		(161,469)
Restricted stock purchased with recourse notes (in Shares)					2,820
Restricted stock awards repurchased					$ (28)	28
Restricted stock awards repurchased (in Shares)					(287,591)
Stock-based compensation						195,056			195,056
Warrants issued in connection with note payable						49,000			49,000
Net loss								(21,855,127)	(21,855,127)						(51,354)	(51,354)					(21,855,127)
Balance Ending at Dec. 31, 2022	$ 309	$ 244	$ 209	$ 36	$ 683	31,232,737	(165,719)	(43,520,645)	(12,452,146)	$ 309	$ 244	$ 209	$ 36	$ 500	(124,043)	(123,543)	$ 683	31,232,737	(165,719)	(43,520,645)	(12,452,146)
Balance Ending (in Shares) at Dec. 31, 2022	3,091,672	2,440,411	2,088,696	357,836	6,826,352					3,091,672	2,440,411	2,088,696	357,836	5,000,000			6,826,352
Balances Beginning at Mar. 31, 2022										$ 309	$ 244	$ 209	$ 36	$ 500	(80,577)	(80,077)	$ 689	31,042,452		(25,607,663)	5,436,275
Balances Beginning (in Shares) at Mar. 31, 2022										3,091,672	2,440,411	2,088,696	357,836	5,000,000			6,893,535
Restricted stock awards repurchased																	$ (2)	2
Restricted stock awards repurchased (in Shares)																	(21,558)
Stock-based compensation																		11,057			11,057
Net loss															(19,190)	(19,190)				(5,300,015)	(5,300,015)
Balance Ending at Jun. 30, 2022										$ 309	$ 244	$ 209	$ 36	$ 500	(99,767)	(99,267)	$ 687	31,053,511		(30,907,678)	147,317
Balance Ending (in Shares) at Jun. 30, 2022										3,091,672	2,440,411	2,088,696	357,836	5,000,000			6,871,977
Restricted stock purchased with recourse notes																		817			817
Restricted stock awards repurchased
Restricted stock awards repurchased (in Shares)																	(1,554)
Stock-based compensation																		93,724	0		93,724
Net loss																				(5,358,605)	(5,358,605)
Balance Ending at Sep. 30, 2022										$ 309	$ 244	$ 209	$ 36				$ 687	31,148,051		(36,266,283)	(5,116,747)
Balance Ending (in Shares) at Sep. 30, 2022										3,091,672	2,440,411	2,088,696	357,836				6,870,423
Balances Beginning at Dec. 31, 2022	$ 309	$ 244	$ 209	$ 36	$ 683	31,232,737	(165,719)	(43,520,645)	(12,452,146)	$ 309	$ 244	$ 209	$ 36	$ 500	(124,043)	(123,543)	$ 683	31,232,737	(165,719)	(43,520,645)	(12,452,146)
Balances Beginning (in Shares) at Dec. 31, 2022	3,091,672	2,440,411	2,088,696	357,836	6,826,352					3,091,672	2,440,411	2,088,696	357,836	5,000,000			6,826,352
Restricted stock purchased with recourse notes																		3,436	(1,202)		2,234
Restricted stock purchased with recourse notes (in Shares)																	2,820
Restricted stock awards repurchased																	$ (24)	20			(4)
Restricted stock awards repurchased (in Shares)																	(238,625)
Stock-based compensation																		93,943			93,943
Net loss															(11,482)	(11,482)				(5,138,122)	(5,138,122)
Balance Ending at Mar. 31, 2023										$ 309	$ 244	$ 209	$ 36	$ 500	(135,525)	(135,025)	$ 659	31,330,136	(166,921)	(48,658,767)	(17,494,095)
Balance Ending (in Shares) at Mar. 31, 2023										3,091,672	2,440,411	2,088,696	357,836	5,000,000			6,590,547
Balances Beginning at Dec. 31, 2022	$ 309	$ 244	$ 209	$ 36	$ 683	31,232,737	(165,719)	(43,520,645)	(12,452,146)	$ 309	$ 244	$ 209	$ 36	$ 500	(124,043)	(123,543)	$ 683	31,232,737	(165,719)	(43,520,645)	(12,452,146)
Balances Beginning (in Shares) at Dec. 31, 2022	3,091,672	2,440,411	2,088,696	357,836	6,826,352					3,091,672	2,440,411	2,088,696	357,836	5,000,000			6,826,352
Net loss																(29,321)
Balance Ending at Jun. 30, 2023										$ 309	$ 244	$ 209	$ 36	$ 500	(153,364)	(152,864)	$ 653	31,440,504	(168,223)	(53,625,023)	(22,351,291)
Balance Ending (in Shares) at Jun. 30, 2023										3,091,672	2,440,411	2,088,696	357,836	5,000,000			6,530,392
Balances Beginning at Dec. 31, 2022	$ 309	$ 244	$ 209	$ 36	$ 683	$ 31,232,737	$ (165,719)	$ (43,520,645)	$ (12,452,146)	$ 309	$ 244	$ 209	$ 36	$ 500	(124,043)	(123,543)	$ 683	31,232,737	(165,719)	(43,520,645)	(12,452,146)
Balances Beginning (in Shares) at Dec. 31, 2022	3,091,672	2,440,411	2,088,696	357,836	6,826,352					3,091,672	2,440,411	2,088,696	357,836	5,000,000			6,826,352
Net loss																					(17,750,350)
Balance Ending at Sep. 30, 2023																	$ 2,436	63,805,874	(168,516)	(61,270,995)	2,368,799
Balance Ending (in Shares) at Sep. 30, 2023																	24,362,444
Balances Beginning at Mar. 31, 2023										$ 309	$ 244	$ 209	$ 36	$ 500	(135,525)	(135,025)	$ 659	31,330,136	(166,921)	(48,658,767)	(17,494,095)
Balances Beginning (in Shares) at Mar. 31, 2023										3,091,672	2,440,411	2,088,696	357,836	5,000,000			6,590,547
Restricted stock purchased with recourse notes																		3,433	(1,302)		2,131
Restricted stock purchased with recourse notes (in Shares)																	2,820
Restricted stock awards repurchased																	$ (6)	6
Restricted stock awards repurchased (in Shares)																	(62,975)
Stock-based compensation																		106,929			106,929
Net loss															(17,839)	(17,839)				(4,966,256)	(4,966,256)
Balance Ending at Jun. 30, 2023										$ 309	$ 244	$ 209	$ 36	$ 500	$ (153,364)	$ (152,864)	$ 653	31,440,504	(168,223)	(53,625,023)	(22,351,291)
Balance Ending (in Shares) at Jun. 30, 2023										3,091,672	2,440,411	2,088,696	357,836	5,000,000			6,530,392
Issuance of common stock pursuant to Merger																	$ 304	12,160,256			12,160,560
Issuance of common stock pursuant to Merger (in Shares)																	3,040,140
Conversion of convertible note and derivative into common stock in connection with Merger																	$ 94	3,751,781			3,751,875
Conversion of convertible note and derivative into common stock in connection with Merger (in Shares)																	937,961
Conversion of SAFEs into common stock in connection with Merger																	$ 437	17,489,967			17,490,404
Conversion of SAFEs into common stock in connection with Merger (in Shares)																	4,372,601
Conversion of preferred stock into common stock in connection with Merger										$ (309)	$ (244)	$ (209)	$ (36)				$ 798
Conversion of preferred stock into common stock in connection with Merger (in Shares)										(3,091,672)	(2,440,411)	(2,088,696)	(357,836)				7,978,616
Predecessor shares converted into common stock upon the Merger																	$ 150	(150)
Predecessor shares converted into common stock upon the Merger (in Shares)																	1,500,000
Restricted stock purchased with recourse notes																		3,433	(293)		3,140
Restricted stock purchased with recourse notes (in Shares)																	2,734
Warrants issued with convertible note																		991,000			991,000
Stock-based compensation																		103,385			103,385
Offering costs																		(2,134,302)			(2,134,302)
Net loss																				(7,645,972)	(7,645,972)
Balance Ending at Sep. 30, 2023																	$ 2,436	$ 63,805,874	$ (168,516)	$ (61,270,995)	$ 2,368,799
Balance Ending (in Shares) at Sep. 30, 2023																	24,362,444

Fair Value Measurements (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Fair Value Measurements [Abstract]

Schedule of Financial Assets and Liabilities Subject to Fair Value Measurements

The Company’s financial assets and liabilities subject to fair value measurements on a recurring basis and the level of inputs used for such measurements were as follows:

Fair Value Measurements
as of September 30, 2023 Using:

Level 1

Level 2

Level 3

Total

Liabilities:

Simple agreement for future equity

Derivative liability

	Fair Value Measurements as of December 31, 2022 Using:
	Level 1		Level 2		Level 3		Total
Liabilities:
Simple agreement for future equity	$	-	$	-	$	13,150,745	$	13,150,745
	$	-	$	-	$	13,150,745	$	13,150,745

The Company’s financial assets and liabilities subject to fair value measurements on a recurring basis and the level of inputs used for such measurements were as follows:

	Fair Value Measurements as of December 31, 2022 Using:
	Level 1		Level 2		Level 3		Total
Liabilities:
Simple agreement for future equity	$	-	$	-	$	13,150,745	$	-
	$	-	$	-	$	13,150,745	$	-

Schedule of Level 3 Liabilities Measured at Fair Value

The following table presents changes in Level 3 liabilities measured at fair value for the periods ended December 31, 2022 and 2021:

	Simple
	Agreement For
	Future Equity
Balance at inception	$	-
Issuance of simple agreements for future equity		7,925,000
Change in fair value		11,043,155
Conversion to Series Seed-1, Seed-2 and Seed-3 preferred stock		(18,968,155	)
Outstanding as of December 31, 2021		-
Issuance of simple agreements for future equity		12,885,001
Change in fair value		265,744
Outstanding as of December 31, 2022	$	13,150,745

Schedule of Changes in Fair Value

The following table sets forth a summary of changes in the fair value of our Level 3 financial instrument liabilities for the nine months ended September 30, 2023:

	Simple Agreement For			Embedded Derivative
	Future Equity			Liability			Total
Outstanding as of December 31, 2022	$	13,150,745		$	-		$	13,150,745
Issuance of simple agreements for future equity		2,666,953			-			2,666,953
Issuance of embedded derivative liability		-			601,000			601,000
Change in fair value		1,672,706			149,000			1,821,706
Conversion to common stock before APO		(17,490,404	)		(750,000	)		(18,240,404	)
Outstanding as of September 30, 2023	$	-		$	-		$	-

- Definition

Tabular disclosure of all significant concentrations of risk, including credit risk and market risk, arising from all financial instruments (as defined), whether from an individual counterparty or groups of counterparties. The disclosure concerning concentrations of risk may consist of the following information: (1) for concentrations of credit risk disclosure may include: (a) information about the (shared) activity, region, or economic characteristic that identifies the concentration, (b) the maximum amount of loss due to credit risk that, based on the gross fair value of the financial instrument, the entity would incur if parties to the financial instruments that make up the concentration failed completely to perform according to the terms of the contracts and the collateral or other security, if any, for the amount due proved to be of no value to the entity, (c) the policy of requiring collateral or other security to support financial instruments subject to credit risk, information about the entity's access to that collateral or other security, and the nature and a brief description of the collateral or other security supporting those financial instruments, and (d) the policy of entering into master netting arrangements to mitigate the credit risk of financial instruments, information about the arrangements for which the entity is a party, and a brief description of the terms of those arrangements, including the extent to which they would reduce the entity's maximum amount of loss due to credit risk and (2) for disclosure of quantitative information about the market risks of financial instruments that is consistent with the way the company manages or adjusts those risks, disclosure may include: (a) more details about current positions and perhaps activity during the period, (b) the hypothetical effects on comprehensive income (or net assets), or annual income, of several possible changes in market prices, (c) a gap analysis of interest rate re-pricing or maturity dates, (d) the duration of the financial instruments, (e) the entity's value at risk from derivatives and from other positions at the end of the reporting period and the average value at risk during the year, or (f) other ways of reporting quantitative information as internally developed.

+ References + Details

Stock-Based Compensation (Details) - Schedule of Stock Options - Previously Reported [Member] - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Jan. 01, 2021
Stock-Based Compensation (Details) - Schedule of Stock Options [Line Items]
Stock options, Outstanding as of Begining balance	861,309	590,073
Weighted Average Exercise Price, Outstanding as of Begining balance (in Dollars per share)	$ 0.49	$ 0.49
Intrinsic Value, Outstanding as of Begining balance (in Dollars)
Stock options, Exercisable as of balance	170,125	335
Weighted Average Exercise Price, Exercisable as of balance (in Dollars per share)	$ 0.49	$ 0.49
Intrinsic Value, Exercisable as of balance (in Dollars)
Stock options, Granted	639,682	590,073
Weighted Average Exercise Price, Granted (in Dollars per share)	$ 0.49	$ 0.49
Stock options, Exercised
Weighted Average Exercise Price, Exercised (in Dollars per share)
Intrinsic Value, Exercised (in Dollars)
Stock options, Forfeited	(368,446)
Weighted Average Exercise Price, Forfeited (in Dollars per share)

Nature of Operations

6 Months Ended

9 Months Ended

12 Months Ended

Jun. 30, 2023

Sep. 30, 2023

Dec. 31, 2022

Nature of Operations [Line Items]

NATURE OF OPERATIONS

1 NATURE OF OPERATIONS

On July 31, 2023, the board of directors of Patricia Acquisition Corp., a Delaware corporation (“Patricia”) and all of its pre-Merger (as defined below) stockholders approved a restated certificate of incorporation, which was effective upon its filing with the Secretary of State of the State of Delaware on July 31, 2023, and through which Patricia changed its name to “Serve Robotics Inc.”

Serve Operating Co. (formerly known as Serve Robotics Inc.) (the “Company” or “Serve”) is a corporation formed on January 15, 2021 under the laws of the State of Delaware. The Company is developing next generation robots for last-mile delivery services. The Company is headquartered in Redwood City, California.

In February 2021, the Company entered into a contribution and license agreement with Postmates, LLC, a Delaware limited liability company (“Postmates”). Pursuant to the agreement, Postmates transferred over certain contracts and agreements, intellectual property and patents and hardware and equipment to the Company. As the contribution was without consideration, the agreement did not have any effect on the Company’s consolidated financial statements.

On July 31, 2023, Patricia’s wholly-owned subsidiary, Serve Acquisition Corp., a corporation formed in the State of Delaware on July 10, 2023 (“Acquisition Sub”), merged with and into the Company. Pursuant to this transaction (the “Merger”), the Company was the surviving corporation and became Patricia’s wholly owned subsidiary, and all of the outstanding stock of Serve was converted into shares of Patricia’s common stock. All of Serve’s outstanding warrants and options were assumed by Patricia. Following the consummation of the Merger, Serve changed its name to “Serve Operating Co.”

Following the closing of the Merger, Patricia Acquisition Corp. changed its name to Serve Robotics Inc.

As a result of the Merger, Patricia acquired the business of Serve and will continue the existing business operations of Serve as a public reporting company under the name Serve Robotics Inc. In accordance with “reverse merger” or “reverse acquisition” accounting treatment, the Company was determined the accounting acquirer. Patricia’s historical financial statements before the Merger has been replaced with the historical financial statements of Serve before the Merger in filings with the SEC since the Merger unless otherwise noted.

1.	NATURE OF OPERATIONS

Serve Robotics, Inc. (the “Company” or “Serve”) is a corporation formed on January 15, 2021 under the laws of the State of Delaware. The Company is developing next generation robots for last-mile delivery services. The Company is headquartered in Redwood City, California.

Patricia Acquisition Corp.[Member]

Nature of Operations [Line Items]

NATURE OF OPERATIONS

Note 1. Nature of Operations

Patricia Acquisition Corp. (the “Company”) was incorporated in the State of Delaware on November 9, 2020. The Company’s management has chosen December 31st for its fiscal year end.

The Company was organized as a vehicle to investigate and, if such investigation warrants, acquire a target company or business seeking the perceived advantages of being a publicly traded corporation. The Company’s principal business objective is to achieve long-term growth potential through a combination with a business, rather than immediate short-term earnings. The Company will not restrict its potential target companies to any specific business, industry, or geographical location. The analysis of business opportunities will be undertaken by, or under the supervision of, the officer and directors of the Company.

Note 1. Nature of Operations

Patricia Acquisition Corp. (the “Company”) was incorporated in the State of Delaware on November 9, 2020. The Company’s management has chosen December 31st for its fiscal year end.

Fair Value Measurements (Details) - Schedule of Financial Assets and Liabilities Subject to Fair Value Measurements - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Fair Value, Inputs, Level 1 [Member]
Liabilities:
Total
Fair Value, Inputs, Level 1 [Member] \| Fair Value, Recurring [Member]
Liabilities:
Total
Fair Value, Inputs, Level 2 [Member]
Liabilities:
Total
Fair Value, Inputs, Level 2 [Member] \| Fair Value, Recurring [Member]
Liabilities:
Total
Fair Value, Inputs, Level 3 [Member]
Liabilities:
Total		13,150,745
Fair Value, Inputs, Level 3 [Member] \| Fair Value, Recurring [Member]
Liabilities:
Total		$ 13,150,745

Note Payable (Details) - USD ($)	1 Months Ended	3 Months Ended		9 Months Ended		12 Months Ended
Note Payable (Details) - USD ($)	Apr. 30, 2023	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2021	Mar. 01, 2025	Jun. 30, 2023	Mar. 31, 2022	Mar. 01, 2022
Note Payable (Details) [Line Items]
Principal amount			$ 83,333		$ 83,333						$ 2,500,000
Note payable interest rate						10.00%
Principal repayments						$ 250,000
Remained outstanding						2,250,000
interest expense						$ 58,463
Warrants have an exercise price (in Dollars per share)						$ 0.49
Warrant exercisable						12 years	12 years
Debt discount amortized interest expense						$ 49,000	$ 49,000
Amortization of debt discount				$ 816,715	9,167	13,600
Repayment of debt				1,658,359
Interest expense		$ 1,483,390	34,112	2,021,996	49,028	$ 636,330
Debt incurred cost				63,840
Converted shares (in Shares)						4,372,601
Proceeds of note payable				$ 750,000	2,500,000	$ 2,500,000
Minimum [Member]
Note Payable (Details) [Line Items]
Net of unamortized discount						35,400
Maximum [Member]
Note Payable (Details) [Line Items]
Net of unamortized discount						2,214,600
Previously Reported [Member]
Note Payable (Details) [Line Items]
Amortization of debt discount						13,600
Repayment of debt						$ 378,524
Silicon Valley Bank [Member]
Note Payable (Details) [Line Items]
Warrants issued (in Shares)						40,292
Warrants have an exercise price (in Dollars per share)		$ 0.49		$ 0.49
Warrant exercisable				12 years
Debt discount amortized interest expense				$ 49,000
Amortization of debt discount				12,250
Promissory note principal amount			$ 83,333		$ 83,333							$ 2,500,000
Bearing interest rate												3.25%
Repayment of debt				750,000
Note payable outstanding		$ 1,500,000		1,500,000
Interest expense				58,315
Silicon Valley Bank [Member] \| Minimum [Member]
Note Payable (Details) [Line Items]
Net of unamortized discount		23,150		23,150
Silicon Valley Bank [Member] \| Maximum [Member]
Note Payable (Details) [Line Items]
Net of unamortized discount		1,476,850		1,476,850
Warrant [Member]
Note Payable (Details) [Line Items]
Warrants issued (in Shares)						40,292
Short-Term Notes [Member]
Note Payable (Details) [Line Items]
Proceeds from short-term				750,000
Loans unpaid principal amount		$ 18		$ 18
Notes exit fee rate		16.00%		16.00%
Repaid notes payable				$ 920,015
Convertible Notes Payable [Member]
Note Payable (Details) [Line Items]
Debt discount amortized interest expense				$ 804,465
Financing cost	$ 3,001,500
Net proceeds cost	2,798,410
Debt incurred cost	$ 203,090
Repayment rate	80.00%
Converted shares (in Shares)	937,961
Converted price (in Dollars per share)	$ 3.2	$ 3.2		$ 3.2
Debt discount amortized cost				$ 601,000
Debt additional paid-in capital				$ 750,000
Warrants to purchase common stock rate				50.00%
Warrants purchase				8.00%
Debt conversion converted instrument conversion price (in Dollars per share)				$ 3.2
Convertible Notes Payable [Member] \| Minimum [Member]
Note Payable (Details) [Line Items]
Unamortized discount		$ 0		$ 0
Convertible Notes Payable [Member] \| Maximum [Member]
Note Payable (Details) [Line Items]
Unamortized discount		0		$ 0
Convertible Notes Payable [Member] \| Bear Interest Payable [Member]
Note Payable (Details) [Line Items]
Bearing interest rate	10.00%
Serve – Chief Executive Officer [Member]
Note Payable (Details) [Line Items]
Note payable interest rate										7.67%
Repayment rate				16.00%
Proceeds of note payable				$ 449,000
Outstanding note payable		$ 151,500		$ 151,500
Serve – Chief Executive Officer [Member] \| Note Payable – Related Party [Member]
Note Payable (Details) [Line Items]
Note fees				$520,840
Forecast [Member]
Note Payable (Details) [Line Items]
Note payable interest rate									3.25%

Stock-Based Compensation

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Stock-Based Compensation [Abstract]

STOCK-BASED COMPENSATION

9. STOCK-BASED COMPENSATION

2023 Equity Incentive Plan

The 2023 Plan permits the grant of incentive stock options, nonstatutory stock options, stock appreciation rights (“SARs”), restricted stock, restricted stock units (“RSUs”) and stock bonus awards (all such types of awards, collectively, “stock awards”).

Subject to adjustments as set forth in the 2023 Plan, the maximum aggregate number of shares of common stock that may be issued under the 2023 Plan will not exceed 1,594,800 shares. The shares may be authorized, but unissued, or reacquired common stock. Furthermore, subject to adjustments as set forth in the 2023 Plan, in no event shall the maximum aggregate number of shares that may be issued under the 2023 Plan pursuant to Incentive Stock Options exceed the number set forth above plus, to the extent allowable under Section 422 of the Code and the regulations promulgated thereunder, any shares that again become available for issuance pursuant to the 2023 Plan.

The number of shares available for issuance under the 2023 Plan may, at the discretion of the Plan Administrator (as defined below), be increased on October 1st of each fiscal year beginning with the 2023 fiscal year until the 2023 Plan terminates, in each case, in an amount equal to the lesser of (i) at the discretion of our board of directors, 4% of the shares of common stock issued and outstanding on the last day of the immediately preceding month on a fully-diluted and as-converted basis and (ii) such other number of shares determined by our board of directors.

To the extent, stock awards or awards or shares issued under the 2021 Plan that are assumed by the Company pursuant to the Merger Agreement (“Existing Plan Awards”) expire or are forfeited or becomes unexerciseable for any reason without having been exercised in full, or are surrendered pursuant to an exchange program (as defined in the 2023 Plan), the unissued shares that were subject thereto shall continue to be available under the 2023 Plan for issuance pursuant to future stock awards. In addition, any shares which are retained by us upon exercise of a stock award or Existing Plan Award in order to satisfy the exercise or purchase price for such stock award or Existing Plan Award or any withholding taxes due with respect to such stock award or Existing Plan Award shall be treated as not issued and shall continue to be available under the 2023 Plan for issuance pursuant to future stock awards. Shares issued under the 2023 Plan or an Existing Plan Award and later forfeited to us due to the failure to vest or repurchased by us at the original purchase price paid to us for the shares (including without limitation upon forfeiture to or repurchase by us in connection with a participant ceasing to be a service provider) shall again be available for future grant under the 2023 Plan. To the extent a stock award under the 2023 Plan or Existing Plan Award is paid out in cash rather than shares, such cash payment will not result in reducing the number of shares available for issuance under the 2023 Plan.

Serve Robotics 2021 Equity Incentive Plan

The Company has adopted the Serve Robotics 2021 Equity Incentive Plan (“2021 Plan”), as amended and restated, which provides for the grant of shares of stock options and stock appreciation rights (“SARs”) and restricted common shares to employees, non-employee directors, and non-employee consultants. The number of shares authorized by the 2021 Plan was 4,870,663 shares as of September 30, 2023. The option exercise price generally may not be less than the underlying stock’s fair market value at the date of the grant and generally have a term of ten years. The amounts granted each calendar year to an employee or non-employee is limited depending on the type of award. As of September 30, 2023, there were 3,275,863 shares available for grant under the 2021 Plan. Stock options granted under the 2021 Plan typically vest over a four-year period, with a one-year cliff as well as via specified milestones.

A summary of information related to stock options for the nine months ended September 30, 2023 is as follows:

	Options			Weighted Average Exercise Price		Intrinsic Value
Outstanding as of December 31, 2022		861,309		$	0.49	$	-
Granted		765,477			0.75
Exercised		-			-
Forfeited		(31,985	)		0.49
Outstanding as of September 30, 2023		1,594,800		$	0.61	$	5,405,876

Exercisable as of September 30, 2023		296,057		$	0.51	$	1,292,215
Exercisable as of December 31, 2022		170,125		$	0.49	$	-

As of September 30, 2023, the weighted average duration to expiration of outstanding options was 8.79 years.

Stock-based compensation expense for stock options of $85,803 and $41,506 was recognized under ASC 718 for the nine months ended September 30, 2023 and 2022, respectively. Total unrecognized compensation cost related to non-vested stock option awards amounted to approximately $521,000 as of September 30, 2023, which will be recognized over a weighted average period of 3.99 years.

The stock options were valued using the Black-Scholes pricing model using the range of inputs as indicated below:

	Nine Months Ended
	September 30,
	2023			2022
Risk-free interest rate		3.58% - 3.91	%		1.9% - 3.01	%
Expected term (in years)		5.52-6.27			6.02-6.27
Expected volatility		75.0	%		79.1	%
Expected dividend yield		0	%		0	%

Warrants

Upon the consummation of the Merger, (i) warrants to purchase 17,314 shares of Serve’s common stock issued and outstanding immediately prior to the closing of the Merger were assumed and converted into warrants to purchase 13,911 shares of Patricia’s common stock, and (ii) warrants to purchase 160,323 shares of Serve’s Series Seed preferred stock issued and outstanding immediately prior to the closing of the Merger were assumed and converted into warrants to purchase 128,819 shares of Patricia’s common stock.

In connection with the April Notes (see Note 6), the Company granted each holder warrants to purchase common stock equal to 50% of the number of shares of common stock into which the loan is convertible into at an exercise price of $3.20 per share. Furthermore, the Company granted warrants to the Bridge Brokers equal to 8% of the number of shares of common stock into which April Notes, other than those purchased by insider investors, would convert at the closing of the Merger, with an exercise price of $3.20 per share. As the issuance of the warrants noted above were contingent on the closing of the Merger, they were not considered granted until July 31, 2023. Upon the closing of the Merger, the Company issued 468,971 warrants to the holders of the April Notes and 74,662 warrants to the Bridge Brokers. The Company calculated the fair value of the warrants using a Black-Scholes pricing model. The Company valued the warrants using a common stock fair value of $4.00, exercise price of $3.20 per share, a term of three years, a volatility of 75% and a risk-free interest rate of 4.18%. The Company allocated the debt proceeds on a relative fair value basis between the note and warrant for shares issued to April Note holders and a discount for the Bridge Brokers, resulting in a note discount totaling $991,000. This was immediately recognized in interest expense as of the note conversion date on July 31, 2023. As of September 30, 2023, all of the warrants were outstanding and were immediately exercisable.

In connection with the Private Placement as of September 30, 2023, the Company granted an additional 392,927 warrants to purchase common stock to the placement agents. Of these, 142,927 warrants had an exercise price of $4.00 per share and 250,000 warrants had an exercise price of $0.001 per share. The warrants are immediately exercisable. These warrants were considered a cost of the offering and had no impact on the financial statements as the offering costs both reduced and added to additional paid-in capital

As of September 30, 2023, there were an aggregate of 1,079,290 warrants to purchase common stock outstanding with a weighted-average exercise price of $2.66 per share.

Classification

Stock-based compensation expense for stock options was classified in the statements of operations as follows:

	Nine Months Ended
	September 30,
	2023		2022
General and administrative	$	33,239	$	12,527
Operations		27,902		7,662
Research and development		232,182		91,552
Sales and marketing		10,933		2,065
	$	304,256	$	113,806

9.	STOCK-BASED COMPENSATION

Serve Robotics 2021 Equity Incentive Plan

The Company has adopted the Serve Robotics 2021 Equity Incentive Plan (“2021 Plan”), as amended and restated, which provides for the grant of shares of stock options and stock appreciation rights (“SARs”) and restricted common shares to employees, non-employee directors, and non-employee consultants. The number of shares authorized by the 2021 Plan was 4,870,663 shares as of December 31, 2022. The option exercise price generally may not be less than the underlying stock’s fair market value at the date of the grant and generally have a term of ten years. The amounts granted each calendar year to an employee or non-employee is limited depending on the type of award. As of December 31, 2022, there were 4,009,354 shares available for grant under the 2021 Plan. Stock options granted under the 2021 Plan typically vest over a four-year period, with a 1-year cliff as well as via specified milestones.

In 2021 and 2022, the Company granted 590,073 and 639,682 options, with weighted average grant date fair values of $0.34 per share.

A summary of information related to stock options for the periods ended December 31, 2022 and 2021 is as follows:

	Options			Weighted Average Exercise Price		Intrinsic Value
Outstanding as of inception		-			-	$	-
Granted		590,073		$	0.49
Exercised		-			-
Forfeited		-			-
Outstanding as of December 31, 2021		590,073			0.49	$	-
Granted		639,682		$	0.49
Exercised		-
Forfeited		(368,446	)
Outstanding as of December 31, 2022		861,309		$	0.49	$	-

Exercisable as of December 31, 2022		170,125		$	0.49	$	-
Exercisable as of December 31, 2021		335		$	0.49	$	-

As of December 31, 2022, the weighted average duration to expiration of outstanding options was 9.2 years.

Of the 2021 options granted; 159,876 options were granted with performance conditions based on specified milestones. As of December 31, 2021, none of these milestones were met or were probable of being met and the Company did not recognize any stock-based compensation expense pertaining to these options. In October 2022, the Company agreed to modify previous common stock and option equity awards that were subject to milestone vesting, to the extent they were still outstanding as of September 15, 2022, to time based vesting. All such awards had the milestones eliminated, and vest monthly over four years. Certain shares are subject to acceleration of vesting upon termination without cause. The value of the options before and after modification were not significantly different. The additional expense upon modification is included in the overall $57,860 of stock compensation from options disclosed above.

Stock-based compensation expense for stock options of $57,860 and $7,111 was recognized under ASC 718 for the periods ended December 31, 2022 and 2021, respectively. Total unrecognized compensation cost related to non-vested stock option awards amounted to approximately $303,000 as of December 31, 2022, which will be recognized over a weighted average period of 2.06 years.

The stock options were valued using the Black-Scholes pricing model using the range of inputs as indicated below:

				For the Period from
				January 15, 2021
	Year Ended			(inception) to
	December 31,			December 31,
	2022			2021
Risk-free interest rate		2.98	%		1.33	%
Expected term (in years)		6.0-6.3			5.5-6.3
Expected volatility		79.1	%		79.1	%
Expected dividend yield		0	%		0	%

Warrants

In connection with the SVB note (see Note 6), the Company issued 40,292 warrants to purchase common stock. The warrants have an exercise price of $0.49 per share, are immediately exercisable and have a term of 12 years. The fair value of the warrant was $49,000. The Black-Scholes inputs used were similar to those described in stock-options above, other than the contractual term was used for expected life.

During the period ended December 31, 2021, the Company granted 13,911 warrants to purchase common stock, exercisable at $3.88 per share. The warrants were valued using the Black-Scholes option-pricing model for a fair value of $0.11 per share and $1,603 was recognized as stock-compensation expense. The warrants vest monthly over 12 months. The Black-Scholes inputs used were similar to those described in stock-options above, other than the contractual term was used for expected life.

During the period ended December 31, 2021 the Company issued 128,819 warrants to purchase shares of preferred stock, exercisable at $3.88 per share. The warrants were valued using the Black-Scholes option pricing model and have a grant-date fair value of $2.78 per share, or total fair value of $373,704 using inputs similar to those described in stock options above other than the contractual term was used for expected life. The warrants vest based on specified milestones. As of December 31, 2022 and 2021, the milestones were not met and no warrants had vested. Therefore, the Company did not recognize any stock-based compensation expense pertaining to these warrants.

Classification

Stock-based compensation expense for stock options was classified in the statements of operations as follows:

	Period Ended
	December 31,
	2022		2021
General and administrative	$	23,650	$	8,714
Operations		14,625		-
Research and development		152,739		-
Sales and marketing		4,042		-
	$	195,056	$	8,714

Commitments and Contingencies (Details) - Schedule of Lease Costs - USD ($)	9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021
Commitments and Contingencies (Details) - Schedule of Lease Costs [Line Items]
Total lease costs	$ 756,570	$ 505,060	$ 621,388	$ 296,519
General and administrative [Member]
Commitments and Contingencies (Details) - Schedule of Lease Costs [Line Items]
Total lease costs	$ 275,544	$ 304,864	$ 621,388	$ 296,519

Stock-Based Compensation (Details) - USD ($)	9 Months Ended		12 Months Ended
Stock-Based Compensation (Details) - USD ($)	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2021
Stock-Based Compensation (Details) [Line Items]
Common stock authorized	300,000,000		300,000,000
Shares available	3,275,863		4,009,354
Weighted Average Number of Shares Issued, Basic			639,682	590,073
Fair value price per share (in Dollars per share)			$ 0.34	$ 0.11	$ 0.11
Expiration of outstanding options	8 years 9 months 14 days		9 years 2 months 12 days
Stock option granted	765,477
Overall stock compensation (in Dollars)			$ 57,860
Stock based compensation expense (in Dollars)	$ 85,803	$ 41,506	57,860	$ 7,111
Total unrecognized compensation (in Dollars)	$ 521,000		$ 303,000
Weighted average period	3 years 11 months 26 days		2 years 21 days
Warrants have an exercise price (in Dollars per share)			$ 0.49
Warrant exercisable			12 years	12 years
Debt discount amortized interest expense (in Dollars)			$ 49,000	$ 49,000
Warrants purchase	1,079,290
Exercise price of per share (in Dollars per share)	$ 2.66
Stock compensation expense (in Dollars)				$ 1,603
Warrants purchase shares				128,819	128,819
Preferred stock price per share (in Dollars per share)				$ 3.88	$ 3.88
Price per share (in Dollars per share)				$ 2.78	$ 2.78
Fair value (in Dollars)				$ 373,704
share issued	1,594,800
Percentage of common stock issued and outstanding	4.00%
Share authorized	4,870,663
Percentage of common stock	8.00%
Warrants issued	468,971
Common Stock Fair Value (in Dollars per share)	$ 4
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price (in Dollars per share)	$ 3.2
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term2	3 years
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum	75.00%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate	4.18%	3.01%	2.98%		1.33%
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition (in Dollars)	$ 991,000
Common Stock [Member]
Stock-Based Compensation (Details) [Line Items]
Common stock authorized			300,000,000
Warrants purchase	17,314
Exercise price of per share (in Dollars per share)	$ 3.2
Percentage of common stock	50.00%
Preferred Stock [Member]
Stock-Based Compensation (Details) [Line Items]
Common stock authorized			21,200,000
Warrants purchase	160,323
Warrant [Member]
Stock-Based Compensation (Details) [Line Items]
Warrants issued			40,292
Warrants purchase				13,911
Exercise price of per share (in Dollars per share)				$ 3.88
Warrants [Member]
Stock-Based Compensation (Details) [Line Items]
Exercise price of per share (in Dollars per share)	$ 0.001
Warrants issued	250,000
SVB [Member]
Stock-Based Compensation (Details) [Line Items]
Warrants issued			40,292
Warrants have an exercise price (in Dollars per share)	$ 0.49
Warrant exercisable	12 years
Debt discount amortized interest expense (in Dollars)	$ 49,000
Private Placement [Member]
Stock-Based Compensation (Details) [Line Items]
Warrants purchase	392,927
Exercise price of per share (in Dollars per share)	$ 4
Warrants issued	142,927
Patricia’s Common Stock [Member]
Stock-Based Compensation (Details) [Line Items]
Warrants purchase	13,911
Patricia’s Common Stock [Member] \| Preferred Stock [Member]
Stock-Based Compensation (Details) [Line Items]
Warrants purchase	128,819
Investors [Member]
Stock-Based Compensation (Details) [Line Items]
Exercise price of per share (in Dollars per share)	$ 3.2
Bridge Brokers [Member]
Stock-Based Compensation (Details) [Line Items]
Warrants issued	74,662
Serve Robotics 2021 Equity Incentive Plan [Member]
Stock-Based Compensation (Details) [Line Items]
Common stock authorized			4,870,663
Stock option granted			159,876

Commitments and Related Party Transactions (Details) - Patricia Acquisition Corp.[Member] - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Commitments and Related Party Transactions (Details) [Line Items]
Interest rate	18.00%	18.00%
Note payable	$ 151,500	$ 114,000	$ 64,960

Stock-Based Compensation (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Stock-Based Compensation [Abstract]

Schedule of Stock Options

A summary of information related to stock options for the periods ended December 31, 2022 and 2021 is as follows:

	Options			Weighted Average Exercise Price		Intrinsic Value
Outstanding as of inception		-			-	$	-
Granted		590,073		$	0.49
Exercised		-			-
Forfeited		-			-
Outstanding as of December 31, 2021		590,073			0.49	$	-
Granted		639,682		$	0.49
Exercised		-
Forfeited		(368,446	)
Outstanding as of December 31, 2022		861,309		$	0.49	$	-

Exercisable as of December 31, 2022		170,125		$	0.49	$	-
Exercisable as of December 31, 2021		335		$	0.49	$	-

Schedule of Black-Scholes Pricing Model

The stock options were valued using the Black-Scholes pricing model using the range of inputs as indicated below:

	Nine Months Ended
	September 30,
	2023			2022
Risk-free interest rate		3.58% - 3.91	%		1.9% - 3.01	%
Expected term (in years)		5.52-6.27			6.02-6.27
Expected volatility		75.0	%		79.1	%
Expected dividend yield		0	%		0	%

The stock options were valued using the Black-Scholes pricing model using the range of inputs as indicated below:

				For the Period from
				January 15, 2021
	Year Ended			(inception) to
	December 31,			December 31,
	2022			2021
Risk-free interest rate		2.98	%		1.33	%
Expected term (in years)		6.0-6.3			5.5-6.3
Expected volatility		79.1	%		79.1	%
Expected dividend yield		0	%		0	%

Schedule of Stock-Based Compensation Expenses

Stock-based compensation expense for stock options was classified in the statements of operations as follows:

	Nine Months Ended
	September 30,
	2023		2022
General and administrative	$	33,239	$	12,527
Operations		27,902		7,662
Research and development		232,182		91,552
Sales and marketing		10,933		2,065
	$	304,256	$	113,806

Stock-based compensation expense for stock options was classified in the statements of operations as follows:

	Period Ended
	December 31,
	2022		2021
General and administrative	$	23,650	$	8,714
Operations		14,625		-
Research and development		152,739		-
Sales and marketing		4,042		-
	$	195,056	$	8,714

Schedule of Information Related to Stock Options

A summary of information related to stock options for the nine months ended September 30, 2023 is as follows:

	Options			Weighted Average Exercise Price		Intrinsic Value
Outstanding as of December 31, 2022		861,309		$	0.49	$	-
Granted		765,477			0.75
Exercised		-			-
Forfeited		(31,985	)		0.49
Outstanding as of September 30, 2023		1,594,800		$	0.61	$	5,405,876

Exercisable as of September 30, 2023		296,057		$	0.51	$	1,292,215
Exercisable as of December 31, 2022		170,125		$	0.49	$	-

Unaudited Condensed Consolidated Statements of Operations (Parentheticals) - $ / shares	3 Months Ended				6 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2023	Jun. 30, 2023	Sep. 30, 2022	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2021
Weighted average common shares outstanding - Diluted (in Shares)	18,528,262		6,871,200				10,674,991	6,990,773	8,583,409		6,997,571
Net loss per common share - Diluted (in Dollars per share)	$ (0.41)		$ (0.78)				$ (1.66)	$ (2.09)	$ (2.55)		$ (3.10)
Patricia Acquisition Corp.
Weighted average common shares outstanding - Diluted (in Shares)		5,000,000		5,000,000	5,000,000	5,000,000			5,000,000	5,000,000
Net loss per common share - Diluted (in Dollars per share)		$ 0.00		$ 0.00	$ (0.01)	$ (0.01)			$ (0.01)	$ (0.01)

- Definition

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-3

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482635/260-10-55-15

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (e)(4)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480175/815-40-65-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480175/815-40-65-1

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-11

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-11

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-7

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482689/260-10-45-2

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 60B
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-4

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482662/260-10-50-1

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(25))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(27))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(23))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1

Reference 15: http://www.xbrl.org/2003/role/exampleRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 52
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482635/260-10-55-52

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482689/260-10-45-7

+ Details

Stock-Based Compensation (Details) - Schedule of Stock-Based Compensation Expenses - Stock Options [Member] - USD ($)	9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021
Stock-Based Compensation (Details) - Schedule of Stock-Based Compensation Expenses [Line Items]
General and administrative			$ 23,650	$ 8,714
Operations	$ 27,902	$ 7,662	14,625
Research and development	232,182	91,552	152,739
Sales and marketing	10,933	2,065	4,042
Stock-based compensation expense	$ 304,256	$ 113,806	$ 195,056	$ 8,714

Unaudited Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Sep. 30, 2023	Jun. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Current assets:
Cash	$ 3,502,140		$ 2,715,719	$ 7,965,861
Accounts receivable	3,955		23,697
Inventory	868,721		618,262	463,422
Prepaid expenses	750,072		81,339
Other current assets				11,163
Total current assets	5,124,888		3,439,017	8,440,446
Property and equipment, net	1,982,001		3,376,427	119,616
Right of use asset	894,127		1,215,968
Deposits	512,659		512,659	96,647
Total assets	8,513,675		8,544,071	8,656,709
Current liabilities:
Note payable - related party	151,500
Current liabilities:
Accounts payable	944,487		162,034	336,314
Accrued liabilities	159,648		37,434
Note payable, current	1,000,000		1,000,000
Right of use liability, current portion	518,877		483,186
Lease liability, current portion	2,081,882		2,214,348
Total current liabilities	4,856,394		3,897,002	336,314
Note payable, net of current portion	476,850		1,214,600
Simple agreements for future equity			13,150,745
Restricted stock award liability	159,716		162,747
Right of use liability	314,829		708,143
Lease liability	337,087		1,862,980
Total liabilities	6,144,876		20,996,217	336,314
Commitments and contingencies
Stockholders’ equity (deficit):
Preferred stock, value
Common stock, value	2,436		683	711
Additional paid-in capital	63,805,874		31,232,737
Subscription receivable	(168,516)		(165,719)
Accumulated deficit	(61,270,995)		(43,520,645)	(21,665,518)
Total stockholders' equity (deficit)	2,368,799	$ (22,351,291)	(12,452,146)	8,320,395
Total liabilities and stockholders’ equity (deficit)	8,513,675		8,544,071	8,656,709
Patricia Acquisition Corp.
Current assets:
Cash		9,236	457	271
Total current assets		9,236	457	271
Total assets		9,236	457	271
Current liabilities
Accounts payable and accrued expenses		10,600	10,000	7,500
Note payable - stockholder		151,500	114,000	64,960
Current liabilities:
Total current liabilities		162,100	124,000	72,460
Total liabilities		162,100	124,000	72,460
Commitments and contingencies
Stockholders’ equity (deficit):
Preferred stock, value
Common stock, value		500	500	500
Accumulated deficit		(153,364)	(124,043)	(72,689)
Total stockholders' equity (deficit)		(152,864)	(123,543)	(72,189)
Total liabilities and stockholders’ equity (deficit)		$ 9,236	457	271
Series Seed Preferred Stock
Stockholders’ equity (deficit):
Preferred stock, value			309
Series Seed-1 Preferred Stock
Stockholders’ equity (deficit):
Preferred stock, value			244
Series Seed-2 Preferred Stock
Stockholders’ equity (deficit):
Preferred stock, value			209
Series Seed-3 Preferred Stock
Stockholders’ equity (deficit):
Preferred stock, value			36
Previously Reported
Stockholders’ equity (deficit):
Additional paid-in capital			31,232,737	29,984,430
Total stockholders' equity (deficit)			(12,452,146)	8,320,395
Previously Reported \| Series Seed Preferred Stock
Stockholders’ equity (deficit):
Preferred stock, value			309	283
Previously Reported \| Series Seed-1 Preferred Stock
Stockholders’ equity (deficit):
Preferred stock, value			244	244
Previously Reported \| Series Seed-2 Preferred Stock
Stockholders’ equity (deficit):
Preferred stock, value			209	209
Previously Reported \| Series Seed-3 Preferred Stock
Stockholders’ equity (deficit):
Preferred stock, value			$ 36	$ 36

Summary of Significant Accounting Policies (Details) - Schedule of Potentially Dilutive Items Outstanding - shares	9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021
Summary of Significant Accounting Policies (Details) - Schedule of Potentially Dilutive Items Outstanding [Line Items]
Total potentially dilutive shares	2,064,369	9,103,044	9,022,946	8,453,780
Series Seed Preferred Stock [Member]
Summary of Significant Accounting Policies (Details) - Schedule of Potentially Dilutive Items Outstanding [Line Items]
Total potentially dilutive shares		3,091,672	3,091,672	2,834,033
Series Seed-1 Preferred Stock [Member]
Summary of Significant Accounting Policies (Details) - Schedule of Potentially Dilutive Items Outstanding [Line Items]
Total potentially dilutive shares		2,440,412	2,440,411	2,440,411
Series Seed-2 Preferred Stock [Member]
Summary of Significant Accounting Policies (Details) - Schedule of Potentially Dilutive Items Outstanding [Line Items]
Total potentially dilutive shares		2,088,696	2,088,696	2,088,696
Series Seed-3 Preferred Stock [Member]
Summary of Significant Accounting Policies (Details) - Schedule of Potentially Dilutive Items Outstanding [Line Items]
Total potentially dilutive shares		357,836	357,836	357,836
Common stock warrants [Member]
Summary of Significant Accounting Policies (Details) - Schedule of Potentially Dilutive Items Outstanding [Line Items]
Total potentially dilutive shares	142,730	54,203	54,203	13,912
Preferred stock warrants [Member]
Summary of Significant Accounting Policies (Details) - Schedule of Potentially Dilutive Items Outstanding [Line Items]
Total potentially dilutive shares		128,819	128,819	128,819
Stock Options [Member]
Summary of Significant Accounting Policies (Details) - Schedule of Potentially Dilutive Items Outstanding [Line Items]
Total potentially dilutive shares	1,594,800	941,406	861,309	590,073

Commitments and Contingencies (Details) - Schedule of Supplemental Cash Flow - USD ($)	9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021
Commitments and Contingencies (Details) - Schedule of Supplemental Cash Flow [Line Items]
Operating cash flows paid for operating leases	$ 411,393	$ 252,997	$ 381,457
Right-of-use assets obtained in exchange for operating lease obligations		$ 1,535,230	$ 1,535,230

Subsequent Events (Details) - USD ($)		1 Months Ended	9 Months Ended
Subsequent Events (Details) - USD ($)	Oct. 26, 2023	Feb. 28, 2022	Oct. 31, 2021	Sep. 30, 2023	Apr. 30, 2023	Dec. 31, 2022
Subsequent Events (Details) [Line Items]
Principle of bridge financing					$ 3,000,000
Financing bear interest						10.00%
Conversion price						80.00%
Financing Receivable, Percent Past Due						50.00%
Total proceeds received amount						$ 2,666,953
Gross proceeds		$ 999,999	$ 10,999,998
Price of per share (in Dollars per share)				$ 0.0001		$ 0.0001
Subsequent Event [Member]
Subsequent Events (Details) [Line Items]
Common stock share issued (in Shares)	143,531
Gross proceeds	$ 547,127
Price of per share (in Dollars per share)	$ 4
Net proceeds	$ 529,127

Stock-Based Compensation (Details) - Schedule of Stock Options were Valued Using the Range of Inputs	9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021
Stock-Based Compensation (Details) - Schedule of Stock Options were Valued Using the Range of Inputs [Line Items]
Risk-free interest rate	4.18%	3.01%	2.98%	1.33%
Expected term (in years)		6 years 3 months 7 days
Expected volatility		79.10%	79.10%	79.10%
Expected dividend yield		0.00%	0.00%	0.00%
Minimum [Member]
Stock-Based Compensation (Details) - Schedule of Stock Options were Valued Using the Range of Inputs [Line Items]
Risk-free interest rate	3.58%
Expected term (in years)	5 years 6 months 7 days		6 years	5 years 6 months
Expected volatility	75.00%
Expected dividend yield	0.00%
Maximum [Member]
Stock-Based Compensation (Details) - Schedule of Stock Options were Valued Using the Range of Inputs [Line Items]
Risk-free interest rate	3.91%	1.90%
Expected term (in years)	6 years 3 months 7 days	6 years 7 days	6 years 3 months 18 days	6 years 3 months 18 days

Stock-Based Compensation (Details) - Schedule of Black-Scholes Pricing Model	9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021
Stock-Based Compensation (Details) - Schedule of Black-Scholes Pricing Model [Line Items]
Risk-free interest rate	4.18%	3.01%	2.98%	1.33%
Expected term (in years)		6 years 3 months 7 days
Expected volatility		79.10%	79.10%	79.10%
Expected dividend yield		0.00%	0.00%	0.00%
Minimum [Member]
Stock-Based Compensation (Details) - Schedule of Black-Scholes Pricing Model [Line Items]
Risk-free interest rate	3.58%
Expected term (in years)	5 years 6 months 7 days		6 years	5 years 6 months
Expected volatility	75.00%
Expected dividend yield	0.00%
Maximum [Member]
Stock-Based Compensation (Details) - Schedule of Black-Scholes Pricing Model [Line Items]
Risk-free interest rate	3.91%	1.90%
Expected term (in years)	6 years 3 months 7 days	6 years 7 days	6 years 3 months 18 days	6 years 3 months 18 days

Going Concern

6 Months Ended

9 Months Ended

12 Months Ended

Jun. 30, 2023

Sep. 30, 2023

Dec. 31, 2022

Going Concern [Line Items]

GOING CONCERN

2 GOING CONCERN

The Company has evaluated whether there are certain conditions and events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date that the consolidated financial statements are issued.

The Company’s ability to continue as a going concern until it reaches profitability is dependent upon its ability to generate cash from operating activities and to raise additional capital to fund operations. There are no assurances than management’s plans will be successful.

2.	GOING CONCERN

The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has sustained net losses of $21,855,127 and $21,665,518 for the periods ended December 31, 2022 and 2021, respectively and has negative cash flow from operations for the periods ended December 31, 2022 and 2021. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern. The Company’s ability to continue as a going concern for the next twelve months is dependent upon its ability to generate sufficient cash flows from operations to meet its obligations, which it has not been able to accomplish to date, and/or to obtain additional capital financing. No assurance can be given that the Company will be successful in these efforts. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities.

Patricia Acquisition Corp.[Member]

Going Concern [Line Items]

GOING CONCERN

Note 6. Going Concern

The accompanying financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the recoverability of assets and the satisfaction of liabilities in the normal course of business.

The Company has accumulated deficit and total stockholders’ deficit of $153,364 and $152,864, respectively, as of June 30, 2023. Management believes these conditions raise substantial doubt about the Company’s ability to continue as a going concern for the twelve months following the date these financial statements are issued. Management intends to finance operations over the next twelve months through additional borrowings on the existing Note.

The accompanying financial statements do not include any adjustments that might be required should the Company be unable to continue as a going concern.

Note 6. Going Concern

The Company has incurred losses from inception of $124,043, has negative working capital of $123,543, and has a stockholders’ deficit of $123,543 as of December 31, 2022. Management believes these conditions raise substantial doubt about the Company’s ability to continue as a going concern for the twelve months following the date these financial statements are issued. Management intends to finance operations over the next twelve months through additional borrowings on the existing Note.

The accompanying financial statements do not include any adjustments that might be required should the Company be unable to continue as a going concern.

Income Taxes (Details) - USD ($)	6 Months Ended	12 Months Ended
Income Taxes (Details) - USD ($)	Jun. 30, 2023	Dec. 31, 2022	Dec. 31, 2021	Sep. 30, 2023
Income Taxes (Details) [Line Items]
Deferred tax assets before valuation allowance		$ 8,978,639	$ 2,982,757
Valuation allowance		65,000,000	2,982,757	$ 65,000,000
Valuation allowance increase		$ 6,043,682	2,982,757
Effective tax rate		28.00%
Deferred tax assets effective tax rate		0.00%
Operating loss carryforwards		$ 31,805,199	$ 10,611,018
Patricia Acquisition Corp.[Member]
Income Taxes (Details) [Line Items]
Deferred tax assets effective tax rate	(21.00%)	(21.00%)	(21.00%)
Gross deferred tax assets	$ 28,400	$ 22,300	$ 11,500
Net operating loss carry-forwards	$ 135,000	106,000	54,600
Previously Reported [Member]
Income Taxes (Details) [Line Items]
Valuation allowance		$ 9,026,439	$ 35,000,000

Property and Equipment, net

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Property, Plant and Equipment [Abstract]

PROPERTY AND EQUIPMENT, NET

5. PROPERTY AND EQUIPMENT, NET

The following is a summary of property and equipment:

	September 30, 2023			December 31, 2022
Office equipment	$	248,240		$	245,747
Robot assets		3,561,288			3,561,288
Total		3,809,528			3,807,035
Less: accumulated depreciation		(1,827,527	)		(430,608	)
Property and equipment, net	$	1,982,001		$	3,376,427

Depreciation expense was $1,396,919 and $40,521 for the nine months ended September 30, 2023 and 2022, respectively.

5.	PROPERTY AND EQUIPMENT, NET

The following is a summary of property and equipment, net at December 31:

	December 31,
	2022			2021
Office equipment	$	245,747		$	162,085
Robot assets		3,561,288			-
Total		3,807,035			162,085
Less: accumulated depreciation		(430,608	)		(42,469	)
Property and equipment, net	$	3,376,427		$	119,616

In November 2022, the Company capitalized $3,561,288 in its next-generation of robot assets, which were financed as part of a failed sales and leaseback transaction (Note 11). Such are held as collateral under the agreement, see Note 11.

Depreciation expense was $388,139 and $42,469 for the periods ended December 31, 2022 and 2021, respectively.

Commitments and Contingencies (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Commitments and Contingencies [Abstract]

Schedule of Lease Costs

The components of lease costs are as follows:

		Nine Months Ended
	Financial Statement	September 30,
Type	Line Item	2023		2022
Operating lease	General and administrative	$	275,544	$	304,864
Operating lease	Operations		326,462		102,242
Operating lease	Research and development		154,564		97,954
Total lease costs		$	756,570	$	505,060

The components of lease costs are as follows:

		Period Ended
	Financial Statement	December 31,
Type	Line Item	2022		2021
Operating lease	General and administrative	$	621,388	$	296,519
Total lease costs		$	621,388	$	296,519

Schedule of Supplemental Cash Flow

Supplemental cash flow information related to leases are as follows:

	Nine Months Ended
	September 30,
	2023		2022
Operating cash flows paid for operating leases	$	411,393	$	252,997
Right-of-use assets obtained in exchange for operating lease obligations	$	-	$	1535,230

Supplemental cash flow information related to leases are as follows:

	Period Ended
	December 31,
	2022		2021
Operating cash flows paid for operating leases	$	381,457	$	-
Right-of-use assets obtained in exchange for operating lease obligations	$	1,535,230	$	-

Schedule of Supplemental Balance Sheet

Supplemental balance sheet information related to leases are as follows:

	September 30,			December 31,
	2023			2022
Weighted-average remaining lease term (in years)		1.55			2.30
Weighted-average discount rate		7.25	%		7.25	%

Supplemental balance sheet information related to leases are as follows:

	December 31,
	2022			2021
Weighted-average remaining lease term (in years)		2.30			n/a
Weighted-average discount rate		7.25	%		n/a

Schedule of Future Principal Payments

Maturities of lease liabilities, as of December 31, 2022, are as follows:

Year Ending December 31,	Operating Leases
2023	$	483,186
2024		527,983
2025		214,776
Total lease payments		1,225,945
Less: imputed interest		(34,616	)
Total lease obligations	$	1,191,329

Schedule of Future Principal Payments

Future principal payments as of December 31, 2022 were as follows:

Year Ending December 31,	Lease Liability
2023	$	2,214,348
2024		1,862,980
Total	$	4,077,328

Future Equity Obligations (Details) - USD ($)	1 Months Ended	9 Months Ended	12 Months Ended
Future Equity Obligations (Details) - USD ($)	Jul. 31, 2023	Sep. 30, 2023	Dec. 31, 2022	Oct. 31, 2022	Dec. 31, 2021
Future Equity Obligations (Details) [Line Items]
Purchase amounts		$ 2,666,953	$ 12,885,001		$ 7,925,000
Valuation cap		$ 65,000,000	65,000,000		2,982,757
Purchase amount			$ 2,300,000
Percentage of discount rate			80.00%
Preferred stock price per share (in Dollars per share)				$ 3.1187
Conversion of fair value			$ 18,968,155
Discount rate		80.00%
Fair value		$ 0			13,150,745
Common Stock [Member]
Future Equity Obligations (Details) [Line Items]
Converted shares of common stock. (in Shares)	4,372,601
Series Seed-1 Preferred Stock [Member]
Future Equity Obligations (Details) [Line Items]
Converted shares (in Shares)			2,440,411
Series Seed-2 Preferred Stock [Member]
Future Equity Obligations (Details) [Line Items]
Converted shares (in Shares)			2,088,696
Series Seed-3 Preferred Stock [Member]
Future Equity Obligations (Details) [Line Items]
Converted shares (in Shares)			357,836
Previously Reported [Member]
Future Equity Obligations (Details) [Line Items]
Valuation cap			$ 9,026,439		$ 35,000,000

Commitments and Contingencies

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Commitments and Contingencies [Line Items]

COMMITMENTS AND CONTINGENCIES

10. COMMITMENTS AND CONTINGENCIES

Leases – Right of Use Asset and Liability

The components of lease costs are as follows:

		Nine Months Ended
	Financial Statement	September 30,
Type	Line Item	2023		2022
Operating lease	General and administrative	$	275,544	$	304,864
Operating lease	Operations		326,462		102,242
Operating lease	Research and development		154,564		97,954
Total lease costs		$	756,570	$	505,060

Supplemental cash flow information related to leases are as follows:

	Nine Months Ended
	September 30,
	2023		2022
Operating cash flows paid for operating leases	$	411,393	$	252,997
Right-of-use assets obtained in exchange for operating lease obligations	$	-	$	1535,230

Supplemental balance sheet information related to leases are as follows:

	September 30,			December 31,
	2023			2022
Weighted-average remaining lease term (in years)		1.55			2.30
Weighted-average discount rate		7.25	%		7.25	%

Finance Lease – Failed Sales-Leaseback

In November 2022, the Company entered into a lease agreement with Farnam Capital for its next-generation of robot assets. As per ASC 842-40-25-1, the transaction was considered a failed sales-leaseback and therefore the lease was accounted for as a financing agreement. In total, the Company received proceeds of $3,561,288 related to robot assets constructed with the same value that are held as collateral. The agreement calls for monthly payments through October 31, 2024 of $189,262 and required a security deposit of $378,524. During the nine months ended September 30, 2023, the Company made repayments totaling $1,658,359. The outstanding liability at September 30, 2023 was $2,418,969. The Company has the option to purchase the assets at the end of the lease for 40% of the original equipment cost.

Commitments

On December 31, 2021, the company entered into a strategic supply agreement with a manufacturer of component parts used for the Company’s robot assets. The agreement calls for a minimum of $2.3 million in purchases over a two-year period ending December 2023. At the end of the two-year period, the vendor may invoice the Company for any shortfall in orders.

The company has minimum spend agreements related to simulation software and storage services. The purchase commitments extend for a period of two to three years.

Contingencies

The Company may be subject to pending legal proceedings and regulatory actions in the ordinary course of business. The results of such proceedings cannot be predicted with certainty, but the Company does not anticipate that the final outcome arising out of any such matters will have a material adverse effect on its business, financial condition or results of operations.

11.

COMMITMENTS AND CONTINGENCIES

Leases – Right of Use Asset and Liability

The Company has elected the practical expedient not to recognize leases with an initial term of 12 months or less on its balance sheet and lease expense is recognized on a straight-line basis over the term of the short-term lease.

The components of lease costs are as follows:

		Period Ended
	Financial Statement	December 31,
Type	Line Item	2022		2021
Operating lease	General and administrative	$	621,388	$	296,519
Total lease costs		$	621,388	$	296,519

Supplemental cash flow information related to leases are as follows:

	Period Ended
	December 31,
	2022		2021
Operating cash flows paid for operating leases	$	381,457	$	-
Right-of-use assets obtained in exchange for operating lease obligations	$	1,535,230	$	-

Supplemental balance sheet information related to leases are as follows:

	December 31,
	2022			2021
Weighted-average remaining lease term (in years)		2.30			n/a
Weighted-average discount rate		7.25	%		n/a

Maturities of lease liabilities, as of December 31, 2022, are as follows:

Year Ending December 31,	Operating Leases
2023	$	483,186
2024		527,983
2025		214,776
Total lease payments		1,225,945
Less: imputed interest		(34,616	)
Total lease obligations	$	1,191,329

Finance Lease – Failed Sales-Leaseback

In November 2022, the Company entered into a lease agreement with Farnam Capital for its next-generation of robot assets. As per ASC 842-40-25-1, the transaction was considered a failed sales and leaseback and therefore, the lease was accounted for as a financing agreement. In total, the Company received proceeds of $4,455,852 related to robot assets constructed that are held as collateral. The agreement calls for payments through October 31, 2024 of $189,262 and required a security deposit of $378,524. Through December 31, 2022, the Company has made principal repayments totaling $378,524. Furthermore, the Company paid $544,422 in interim payments during the asset construction process which was recorded as interest expense. The outstanding lease liability at December 31, 2022 was $4,077,328. The Company has the option to purchase the assets at the end of the lease for 40% of the original equipment cost.

Future principal payments as of December 31, 2022 were as follows:

Year Ending December 31,	Lease Liability
2023	$	2,214,348
2024		1,862,980
Total	$	4,077,328

Commitments

The company has minimum spend agreements related to simulation software and storage services. The purchase commitments extend for a period of two to three years.

Contingencies

The Company may be subject to pending legal proceedings and regulatory actions in the ordinary course of business. The results of such proceedings cannot be predicted with certainty, but the Company does not anticipate that the final outcome, if any, arising out of any such matters will have a material adverse effect on its business, financial condition or results of operations.

Patricia Acquisition Corp.[Member]

Commitments and Contingencies [Line Items]

COMMITMENTS AND CONTINGENCIES

Note 7. Contingencies - COVID-19

On March 11, 2020, the World Health Organization officially declared the outbreak of the novel coronavirus COVID-19 a “pandemic.” A significant outbreak of COVID-19 and other infectious diseases has resulted in a widespread health crisis that has significantly adversely affected businesses of all types, economies and financial markets worldwide. The business of any potential target company with which the Company consummates a business combination could be materially and adversely affected. Furthermore, the Company may be unable to complete a business combination if continued concerns relating to COVID-19 restrict travel, limit the ability to have meetings with potential investors or the target company’s personnel, vendors and services providers are unavailable to negotiate and consummate a transaction in a timely manner. The extent to which COVID-19 impacts our search for a business combination will depend on future developments, which are highly uncertain and cannot be predicted, including new information which may emerge concerning the severity of COVID-19 and the actions to contain COVID-19 or treat its impact, among others. If the disruptions posed by COVID-19 or other matters of global concern continue for an extended period of time, the Company’s ability to consummate a business combination, or the operations of a target business with which the Company ultimately consummates a business combination, may be materially adversely affected.

Going Concern (Details) - USD ($)	6 Months Ended	9 Months Ended	12 Months Ended
Going Concern (Details) - USD ($)	Jun. 30, 2023	Sep. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Going Concern (Details) [Line Items]
Cash used in operations		$ (17,750,350)	$ 21,855,127	$ 21,665,518
Cash used in operations		$ 12,445,848
Patricia Acquisition Corp.[Member]
Going Concern (Details) [Line Items]
Accumulated deficit	$ 153,364
Stockholders' deficit	$ 152,864		124,043
Working capital			123,543
Net losses			$ 123,543

Stockholders' Equity (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Stockholders’ Equity [Abstract]

Schedule of Liquidation

The liquidation preferences were as follows:

	September 30,		December 31,
	2023		2022
Series Seed preferred stock	$	-	$	11,999,997
Series Seed-1 preferred stock		-		3,699,950
Series Seed-2 preferred stock		-		5,674,962
Series Seed-3 preferred stock		-		1,250,000
	$	-	$	22,624,909

As of December 31, 2022 and 2021, the liquidation preferences were as follows:

	December 31,
	2022		2021
Series Seed preferred stock	$	11,999,997	$	10,999,998
Series Seed-1 preferred stock		3,699,950		3,699,950
Series Seed-2 preferred stock		5,674,962		5,674,962
Series Seed-3 preferred stock		1,250,000		1,250,000
	$	22,629,909	$	21,624,910

Summary of Significant Accounting Policies (Details) - Schedule of Business Combination are Excluded from such Pro-Forma	Dec. 31, 2022 USD ($)
Actual [Member]
Summary of Significant Accounting Policies (Details) - Schedule of Business Combination are Excluded from such Pro-Forma [Line Items]
Common stock	$ 683
Additional paid-in capital	31,232,737
Subscription receivable	(165,719)
Accumulated deficit	(43,520,645)
Total stockholders’ deficit	(12,452,146)
Actual [Member] \| Series Seed Preferred Stock [Member]
Summary of Significant Accounting Policies (Details) - Schedule of Business Combination are Excluded from such Pro-Forma [Line Items]
Preferred stock, value	309
Actual [Member] \| Series Seed-1 Preferred Stock [Member]
Summary of Significant Accounting Policies (Details) - Schedule of Business Combination are Excluded from such Pro-Forma [Line Items]
Preferred stock, value	244
Actual [Member] \| Series Seed-2 Preferred Stock [Member]
Summary of Significant Accounting Policies (Details) - Schedule of Business Combination are Excluded from such Pro-Forma [Line Items]
Preferred stock, value	209
Actual [Member] \| Series Seed-3 Preferred Stock [Member]
Summary of Significant Accounting Policies (Details) - Schedule of Business Combination are Excluded from such Pro-Forma [Line Items]
Preferred stock, value	36
Pro Forma [Member]
Summary of Significant Accounting Policies (Details) - Schedule of Business Combination are Excluded from such Pro-Forma [Line Items]
Common stock	1,481
Additional paid-in capital	31,232,737
Subscription receivable	(165,719)
Accumulated deficit	(43,520,645)
Total stockholders’ deficit	(12,452,146)
Pro Forma [Member] \| Series Seed Preferred Stock [Member]
Summary of Significant Accounting Policies (Details) - Schedule of Business Combination are Excluded from such Pro-Forma [Line Items]
Preferred stock, value
Pro Forma [Member] \| Series Seed-1 Preferred Stock [Member]
Summary of Significant Accounting Policies (Details) - Schedule of Business Combination are Excluded from such Pro-Forma [Line Items]
Preferred stock, value
Pro Forma [Member] \| Series Seed-2 Preferred Stock [Member]
Summary of Significant Accounting Policies (Details) - Schedule of Business Combination are Excluded from such Pro-Forma [Line Items]
Preferred stock, value
Pro Forma [Member] \| Series Seed-3 Preferred Stock [Member]
Summary of Significant Accounting Policies (Details) - Schedule of Business Combination are Excluded from such Pro-Forma [Line Items]
Preferred stock, value

Unaudited Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) - $ / shares

Sep. 30, 2023

Jun. 30, 2023

Dec. 31, 2022

Dec. 31, 2021

Preferred stock, par value (in Dollars per share)

$ 0.0001

Preferred stock, shares authorized

10,000,000

Preferred stock, shares issued

Preferred stock, shares outstanding

Common stock, par value (in Dollars per share)

$ 0.0001

Common stock, shares authorized

300,000,000

Common stock, shares issued

24,689,283

7,161,654

7,111,123

Common stock, shares outstanding

24,362,444

6,826,352

7,111,123

Patricia Acquisition Corp.

Preferred stock, par value (in Dollars per share)

$ 0.0001

Preferred stock, shares authorized

10,000,000

Preferred stock, shares issued

Preferred stock, shares outstanding

Common stock, par value (in Dollars per share)

$ 0.0001

Common stock, shares authorized

50,000,000

Common stock, shares issued

5,000,000

Common stock, shares outstanding

5,000,000

Series Seed Preferred Stock

Preferred stock, par value (in Dollars per share)

$ 0.0001

Preferred stock, shares authorized

4,008,079

Preferred stock, shares issued

3,091,672

Preferred stock, shares outstanding

3,091,672

Series Seed-1 Preferred Stock

Preferred stock, par value (in Dollars per share)

$ 0.0001

Preferred stock, shares authorized

3,037,227

Preferred stock, shares issued

2,440,411

Preferred stock, shares outstanding

2,440,411

Series Seed-2 Preferred Stock

Preferred stock, par value (in Dollars per share)

$ 0.0001

Preferred stock, shares authorized

2,599,497

Preferred stock, shares issued

2,088,696

Preferred stock, shares outstanding

2,088,696

Series Seed-3 Preferred Stock

Preferred stock, par value (in Dollars per share)

$ 0.0001

Preferred stock, shares authorized

445,347

Preferred stock, shares issued

357,836

Preferred stock, shares outstanding

357,836

Previously Reported

Common stock, shares authorized

^[1]

21,200,000

Previously Reported | Series Seed Preferred Stock

Preferred stock, par value (in Dollars per share)

$ 0.0001

Preferred stock, shares authorized

^[1]

4,008,079

Preferred stock, shares issued

3,091,672

2,834,033

Preferred stock, shares outstanding

3,091,672

2,834,033

Previously Reported | Series Seed-1 Preferred Stock

Preferred stock, par value (in Dollars per share)

$ 0.0001

Preferred stock, shares authorized

^[1]

3,037,227

Preferred stock, shares issued

2,440,411

Preferred stock, shares outstanding

2,440,411

Previously Reported | Series Seed-2 Preferred Stock

Preferred stock, par value (in Dollars per share)

$ 0.0001

Preferred stock, shares authorized

^[1]

2,599,497

Preferred stock, shares issued

2,088,696

Preferred stock, shares outstanding

2,088,696

Previously Reported | Series Seed-3 Preferred Stock

Preferred stock, par value (in Dollars per share)

$ 0.0001

Preferred stock, shares authorized

^[1]

445,347

Preferred stock, shares issued

357,836

Preferred stock, shares outstanding

357,836

[1]

The authorized shares of preferred and common stock in the consolidated balance sheets above reflect the historical authorized shares of Serve. Upon the Merger, there were 10,000,000 authorized shares of preferred stock and 300,000,000 shares of common stock. Shares issued and outstanding have been retroactively restated to reflect the exchange ratio of 0.8035 as described in Note 3.

Property and Equipment, net (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Property, Plant and Equipment [Abstract]

Schedule of Property and Equipment, Net

The following is a summary of property and equipment:

	September 30, 2023			December 31, 2022
Office equipment	$	248,240		$	245,747
Robot assets		3,561,288			3,561,288
Total		3,809,528			3,807,035
Less: accumulated depreciation		(1,827,527	)		(430,608	)
Property and equipment, net	$	1,982,001		$	3,376,427

The following is a summary of property and equipment, net at December 31:

	December 31,
	2022			2021
Office equipment	$	245,747		$	162,085
Robot assets		3,561,288			-
Total		3,807,035			162,085
Less: accumulated depreciation		(430,608	)		(42,469	)
Property and equipment, net	$	3,376,427		$	119,616

Commitments and Contingencies (Details) - Schedule of Lease Costs - USD ($)	9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021
Commitments and Contingencies (Details) - Schedule of Lease Costs [Line Items]
Operating lease	$ 756,570	$ 505,060	$ 621,388	$ 296,519
General and administrative [Member]
Commitments and Contingencies (Details) - Schedule of Lease Costs [Line Items]
Operating lease	275,544	304,864	$ 621,388	$ 296,519
Operations [Member]
Commitments and Contingencies (Details) - Schedule of Lease Costs [Line Items]
Operating lease	326,462	102,242
Research and development [Member]
Commitments and Contingencies (Details) - Schedule of Lease Costs [Line Items]
Operating lease	$ 154,564	$ 97,954

Fair Value Measurements (Details) - USD ($)	12 Months Ended
Fair Value Measurements (Details) - USD ($)	Dec. 31, 2022	Sep. 30, 2023
Fair Value Measurements (Details) [Line Items]
Percentage of liquidity, equity financing	85.00%
Equity conversion percentage		100.00%
Net asset value per share (in Dollars per share)	$ 4
Converted shares (in Shares)	4,372,601
Fair value of assets (in Dollars)	$ 17,490,404
Minimum [Member]
Fair Value Measurements (Details) [Line Items]
Operating Leases, Income Statement, Percentage Revenue (in Dollars)	$ 85
Maximum [Member]
Fair Value Measurements (Details) [Line Items]
Equity conversion percentage	100.00%

- Definition

Net asset value per share or per unit of investments in certain entities that calculate net asset value per share. Includes, but is not limited to, by unit, membership interest, or other ownership interest. Investment includes, but is not limited to, investment in certain hedge funds, venture capital funds, private equity funds, real estate partnerships or funds. Excludes fair value disclosure.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 35
-Paragraph 54B
-SubTopic 10
-Topic 820
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482134/820-10-35-54B

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 35
-Paragraph 59
-SubTopic 10
-Topic 820
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482134/820-10-35-59

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 6A
-SubTopic 10
-Topic 820
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482106/820-10-50-6A

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Topic 946
-SubTopic 830
-Name Accounting Standards Codification
-Section 55
-Paragraph 12
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480167/946-830-55-12

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 45
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480555/946-210-45-4

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 205
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480737/946-205-50-7

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 205
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480737/946-205-50-7

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 505
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481004/946-505-50-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-04(19))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.6-05(4))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2

+ Details

Commitments and Related Party Transactions	6 Months Ended	12 Months Ended
Commitments and Related Party Transactions	Jun. 30, 2023	Dec. 31, 2022
Patricia Acquisition Corp.[Member]
Commitments and Related Party Transactions [Line Items]
Commitments and Related Party Transactions	Note 5. Commitments and Related Party Transactions Office Space The Company utilizes the office space and equipment of its management at no cost. Note Payable – Stockholder On November 13, 2020, the Company issued a promissory note (the “Note”) to the majority stockholder of the Company pursuant to which the Company agreed to repay the sum of any and all amounts advanced to the Company, on or before the date that the Company consummates a business combination with a private company or reverse takeover transaction or other transaction, after which the Company would cease to be a shell company. Interest shall not accrue on the outstanding principal amount of the note except if an Event of Default (as defined in the note) has occurred. In the event of an Event of Default, the entire note shall automatically become due and payable (the “Default Date”) and starting from five (5) days after the Default Date, the interest rate on the note shall accrue at the rate of eighteen percent (18%) per annum. As of June 30, 2023 and December 31, 2022, the amount due under the note payable was $151,500 and $114,000, respectively.	Note 5. Commitments and Related Party Transactions Office Space The Company utilizes the office space and equipment of its management at no cost. Note Payable - Stockholder On November 13, 2020, the Company issued a promissory note (the “Note”) to the majority stockholder of the Company pursuant to which the Company agreed to repay the sum of any and all amounts advanced to the Company, on or before the date that the Company consummates a business combination with a private company or reverse takeover transaction or other transaction, after which the Company would cease to be a shell company. In the event of an Event of Default, the entire note shall automatically become due and payable (the “Default Date”) and starting from five (5) days after the Default Date, the interest rate on the note shall accrue at the rate of eighteen percent (18%) per annum. As of December 31, 2022 and 2021, the amount due under the note payable was $114,000 and $64,960, respectively.

- Definition

The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480990/946-20-50-2

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480990/946-20-50-5

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480990/946-20-50-6

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 235
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481062/946-235-50-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 235
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481062/946-235-50-2

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483326/850-10-50-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(g)(3))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(c))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(e))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org//850/tableOfContent

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483326/850-10-50-6

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483326/850-10-50-1

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483326/850-10-50-1

+ Details

Stockholders' Equity (Details) - USD ($)

1 Months Ended

9 Months Ended

12 Months Ended

Aug. 31, 2023

Feb. 28, 2022

Sep. 30, 2023

Sep. 30, 2022

Oct. 31, 2021

Dec. 31, 2022

Dec. 31, 2021

Jul. 31, 2023

Jun. 30, 2023

Oct. 31, 2022

Stockholders' Equity (Details) [Line Items]

Preferred stock, shares issued

Preferred stock amount percentage

8.00%

Preferred Stock issued perice (in Dollars per share)

$ 3.1187

Public offering cost (in Dollars)

$ 50,000,000

Common stock, par value (in Dollars per share)

$ 0.0001

Shares issued

1,594,800

Private placement offering for gross proceeds (in Dollars)

$ 999,999

$ 10,999,998

Per share value (in Dollars per share)

$ 0.0001

Common stock, shares authorized

300,000,000

Common stock, shares issued

24,689,283

7,161,654

7,111,123

Shares of restricted common stock issued

338,121

3,575,723

Total recourse notes (in Dollars)

$ 164,116

$ 4,646

Restricted shares

1,208,846

Addition stock issued (in Dollars)

$ 137,196

Shares of restricted common stock issued

338,121

Subscription receivable (in Dollars)

$ 168,516

$ 165,719

Restricted stock award liability (in Dollars)

$ 159,716

162,747

Stock compensation (in Dollars)

$ 4,250

Shares of restricted common stock

2,354,466

Common stock, shares outstanding

24,362,444

6,826,352

7,111,123

Vesting of restricted common stock (in Dollars)

$ 218,453

$ 72,300

$ 141,446

$ 0

Repurchased restricted stock awards

301,600

287,591

Preferred stock, shares authorized

10,000,000

Preferred stock, par value (in Dollars per share)

$ 0.0001

Preferred stock, shares outstanding

Common stock value (in Dollars)

$ 2,436

$ 683

$ 711

Gross proceeds (in Dollars)

$ 999,999

Converted shares of common stock

7,978,616

Shares of common stock

937,961

Common stock vested value (in Dollars)

$ 10,302

Repurchase shares of common stock

240,700

Preferred Stock [Member]

Stockholders' Equity (Details) [Line Items]

Common stock, par value (in Dollars per share)

$ 11.6442

Common stock, shares authorized

21,200,000

Common Stock [Member]

Stockholders' Equity (Details) [Line Items]

Common stock, par value (in Dollars per share)

$ 0.0001

Common stock, shares authorized

300,000,000

Common stock, shares issued

7,161,654

3,535,400

Common stock, shares outstanding

6,826,352

Founders [Member]

Stockholders' Equity (Details) [Line Items]

Common stock, par value (in Dollars per share)

$ 4,400

Previously Reported [Member]

Stockholders' Equity (Details) [Line Items]

Common stock, shares authorized

^[1]

21,200,000

Restricted Stocks [Member]

Stockholders' Equity (Details) [Line Items]

Shares of restricted common stock

3,185,037

Private Placement [Member]

Stockholders' Equity (Details) [Line Items]

Common stock, par value (in Dollars per share)

$ 4

Private placement offering for gross proceeds (in Dollars)

$ 1,031,048

$ 11,129,512

Common stock, shares issued

257,762

2,782,378

Patricia Acquisition Corp.[Member]

Stockholders' Equity (Details) [Line Items]

Preferred stock, shares issued

Common stock, par value (in Dollars per share)

$ 0.0001

Common stock, shares authorized

50,000,000

Common stock, shares issued

5,000,000

Common stock, shares outstanding

5,000,000

Preferred stock, shares authorized

10,000,000

Preferred stock, par value (in Dollars per share)

$ 0.0001

Preferred stock, shares outstanding

Common stock value (in Dollars)

$ 500

Convertible Preferred Stock [Member] | Preferred Stock [Member]

Stockholders' Equity (Details) [Line Items]

Preferred stock, shares issued

10,090,150

Series Seed Preferred Stock [Member]

Stockholders' Equity (Details) [Line Items]

Preferred stock, shares issued

3,091,672

Shares issued

257,639

2,834,033

Per share value (in Dollars per share)

$ 3.8814

Preferred stock, shares authorized

4,008,079

Preferred stock, par value (in Dollars per share)

$ 0.0001

Preferred stock, shares outstanding

3,091,672

Series Seed Preferred Stock [Member] | Preferred Stock [Member]

Stockholders' Equity (Details) [Line Items]

Preferred stock, shares issued

4,008,079

Preferred Stock issued perice (in Dollars per share)

$ 3.8814

Preferred stock issued (in Dollars per share)

$ 3.8814

Series Seed Preferred Stock [Member] | Previously Reported [Member]

Stockholders' Equity (Details) [Line Items]

Preferred stock, shares issued

3,091,672

2,834,033

Shares issued

257,639

Per share value (in Dollars per share)

$ 3.88

Preferred stock, shares authorized

^[1]

4,008,079

Preferred stock, par value (in Dollars per share)

$ 0.0001

Preferred stock, shares outstanding

3,091,672

2,834,033

Series Seed-1 Preferred Stock [Member]

Stockholders' Equity (Details) [Line Items]

Preferred stock, shares issued

2,440,411

Preferred stock issued (in Dollars per share)

$ 1.5161

Preferred stock, shares authorized

3,037,227

Preferred stock, par value (in Dollars per share)

$ 0.0001

Preferred stock, shares outstanding

2,440,411

Series Seed-1 Preferred Stock [Member] | Preferred Stock [Member]

Stockholders' Equity (Details) [Line Items]

Preferred stock, shares issued

3,037,227

Preferred Stock issued perice (in Dollars per share)

$ 1.5161

Preferred stock issued (in Dollars per share)

$ 2.717

Series Seed-1 Preferred Stock [Member] | Previously Reported [Member]

Stockholders' Equity (Details) [Line Items]

Preferred stock, shares issued

2,440,411

Preferred stock, shares authorized

^[1]

3,037,227

Preferred stock, par value (in Dollars per share)

$ 0.0001

Preferred stock, shares outstanding

2,440,411

Series Seed-2 Preferred Stock [Member]

Stockholders' Equity (Details) [Line Items]

Preferred stock, shares issued

2,088,696

Preferred stock, shares authorized

2,599,497

Preferred stock, par value (in Dollars per share)

$ 0.0001

Preferred stock, shares outstanding

2,088,696

Series Seed-2 Preferred Stock [Member] | Preferred Stock [Member]

Stockholders' Equity (Details) [Line Items]

Preferred stock, shares issued

2,599,497

Preferred Stock issued perice (in Dollars per share)

$ 2.717

Series Seed-2 Preferred Stock [Member] | Previously Reported [Member]

Stockholders' Equity (Details) [Line Items]

Preferred stock, shares issued

2,088,696

Preferred stock, shares authorized

^[1]

2,599,497

Preferred stock, par value (in Dollars per share)

$ 0.0001

Preferred stock, shares outstanding

2,088,696

Series Seed-3 Preferred Stock [Member]

Stockholders' Equity (Details) [Line Items]

Preferred stock, shares issued

357,836

Preferred stock, shares authorized

445,347

Preferred stock, par value (in Dollars per share)

$ 0.0001

Preferred stock, shares outstanding

357,836

Series Seed-3 Preferred Stock [Member] | Preferred Stock [Member]

Stockholders' Equity (Details) [Line Items]

Preferred stock, shares issued

445,437

Preferred Stock issued perice (in Dollars per share)

$ 3.4932

Preferred stock issued (in Dollars per share)

$ 3.4932

Series Seed-3 Preferred Stock [Member] | Previously Reported [Member]

Stockholders' Equity (Details) [Line Items]

Preferred stock, shares issued

357,836

Preferred stock, shares authorized

^[1]

445,347

Preferred stock, par value (in Dollars per share)

$ 0.0001

Preferred stock, shares outstanding

357,836

Common Stock [Member]

Stockholders' Equity (Details) [Line Items]

Common stock, par value (in Dollars per share)

$ 0.0001

Restricted Stock [Member]

Stockholders' Equity (Details) [Line Items]

Shares of restricted common stock

8,375

Preferred Stock [Member] | Convertible Preferred Stock [Member]

Stockholders' Equity (Details) [Line Items]

Preferred stock, shares issued

10,090,150

Preferred Stock [Member] | Series Seed Preferred Stock [Member]

Stockholders' Equity (Details) [Line Items]

Preferred stock, shares issued

4,008,079

Preferred Stock [Member] | Series Seed-1 Preferred Stock [Member]

Stockholders' Equity (Details) [Line Items]

Preferred stock, shares issued

3,037,227

Preferred Stock [Member] | Series Seed-2 Preferred Stock [Member]

Stockholders' Equity (Details) [Line Items]

Preferred stock, shares issued

2,599,497

Preferred Stock [Member] | Series Seed-3 Preferred Stock [Member]

Stockholders' Equity (Details) [Line Items]

Preferred stock, shares issued

445,437

Common Stock [Member]

Stockholders' Equity (Details) [Line Items]

Common stock, shares authorized

300,000,000

Founders [Member] | Patricia Acquisition Corp.[Member]

Stockholders' Equity (Details) [Line Items]

Common stock, par value (in Dollars per share)

$ 0.0001

Common stock value (in Dollars)

$ 500

Restricted Stocks [Member]

Stockholders' Equity (Details) [Line Items]

Common stock, shares outstanding

6,533,167

Restricted Stock [Member]

Stockholders' Equity (Details) [Line Items]

Common stock, shares issued

6,860,053

Patricia [Member]

Stockholders' Equity (Details) [Line Items]

Converted shares of common stock

1,500,000

SAFE [Member]

Stockholders' Equity (Details) [Line Items]

Converted shares of common stock

4,372,601

[1]

Note Payable (Tables)

12 Months Ended

Dec. 31, 2022

Note Payable [Abstract]

Schedule of Future Principal Payments Owed

As of December 31, 2022, note payable, net of unamortized discount of $35,400, was $2,214,600. The following is a summary of future principal payments owed as of December 31, 2022:

Year Ending December 31,
2023	$	1,000,000
2024		1,000,000
2025		250,000
	$	2,250,000

Commitments and Contingencies (Details) - Schedule of Supplemental Balance Sheet	Sep. 30, 2023	Dec. 31, 2022
Schedule of Supplemental Balance Sheet [Abstract]
Weighted-average remaining lease term (in years)	1 year 6 months 18 days	2 years 3 months 18 days
Weighted-average discount rate	7.25%	7.25%

Stockholders' Equity

6 Months Ended

9 Months Ended

12 Months Ended

Jun. 30, 2023

Sep. 30, 2023

Dec. 31, 2022

Stockholders' Equity [Line Items]

STOCKHOLDERS’ EQUITY

8. STOCKHOLDERS’ EQUITY

Preferred Stock

Before the consummation of the Merger, the Company had issued Series Seed, Series Seed-1, Series Seed-2 and Series Seed-3 convertible preferred stock (collectively referred to as “Preferred Stock”). The Company’s certificate of incorporation, as amended and restated, had authorized the Company to issue a total of 10,090,150 shares of Preferred Stock, of which 4,008,079 shares were designated as Series Seed Preferred Stock, 3,037,227 shares were designated as Series Seed-1 Preferred Stock, 2,599,497 shares were designated as Series Seed-2 Preferred Stock and 445,437 shares were designated as Series Seed-3 Preferred Stock.

The liquidation preferences were as follows:

	September 30,		December 31,
	2023		2022
Series Seed preferred stock	$	-	$	11,999,997
Series Seed-1 preferred stock		-		3,699,950
Series Seed-2 preferred stock		-		5,674,962
Series Seed-3 preferred stock		-		1,250,000
	$	-	$	22,624,909

Upon the Merger, there were 10,000,000 shares of preferred stock, par value $0.0001 per share, authorized for issuance.

Transactions

In February 2022, the Company issued 257,639 shares of Series Seed Preferred Stock for gross proceeds of $999,999, or $3.88 per share.

Upon consummation of the Merger in July 2023, all shares of Serve Preferred Stock were converted into 7,978,616 shares of common stock of the newly merged entity.

Common Stock

Upon the Merger, the Company has authorized 300,000,000 shares of common stock, par value $0.0001 per share.

Dividend Rights

Subject to applicable law and the rights and preferences, if any, of any holders of any outstanding series of preferred stock, the holders of our common stock are entitled to receive dividends if our board of directors, in its discretion, determines to issue dividends and then only at the times and in the amounts that our board of directors may determine, payable either in cash, in property or in shares of capital stock.

Voting Rights

Holders of our common stock are entitled to one vote for each share of common stock held on all matters submitted to a vote of stockholders. Except as otherwise required by law, holders of common stock are not entitled to vote on any amendment to the amended and restated certificate of incorporation (including any certificate of designation relating to any series of preferred stock) that relates solely to the terms of one or more outstanding series of preferred stock if the holders of such affected series are entitled, either separately or together as a class with the holders of one or more other such series, to vote on such amendment pursuant to the amended and restated certificate (including any certificate of designation relating to any series of preferred stock). We have not provided for cumulative voting for the election of directors in our amended and restated certificate of incorporation. Accordingly, holders of a majority of the shares of our common stock will be able to elect all of our directors. Our amended and restated certificate of incorporation establishes a classified board of directors, divided into three classes with staggered three-year terms. Only one class of directors will be elected at each annual meeting of our stockholders, with the other classes continuing for the remainder of their respective three-year terms.

Transactions

Immediately following the Merger, the Company issued 2,782,378 shares of common stock pursuant to a private placement offering for gross proceeds of $11,129,512, or at a purchase price of $4.00 per share. On August 31, 2023, the Company issued an additional 257,762 shares of common stock pursuant to the private placement offering for gross proceeds of $1,031,048, or $4.00 per share. The private placement offerings are referred to herein as the “Private Placement.”

Upon consummation of the Merger, Patricia’s predecessor shares converted into 1,500,000 shares of common stock of the newly merged entity.

Upon consummation of the Merger, all outstanding SAFEs were converted into 4,372,601 shares of common stock (see Notes 4 and 7).

Upon consummation of the Merger, the outstanding convertible note and related derivative liability was converted into 937,961 shares of common stock (see Notes 4 and 6).

Upon consummation of the Merger, all shares of Serve Preferred Stock were converted into 7,978,616 shares of common stock.

Restricted Common Stock

During 2022, the Company issued 338,121 shares of restricted common stock for recourse notes totaling $164,116. The shares were issued with a corresponding note receivable, a recourse loan that was collateralized by the underlying shares. The Company plans to enforce the recourse terms for the holders. As such, in accordance with ASC 505-10-45-2, the Company recognized a subscription receivable of $165,719, inclusive of interest on the note, which is included as a contra-equity on the consolidated balance sheets. The Company recorded a corresponding restricted stock award liability of $162,747 for the potential settlement if the call right for the shares of restricted common stock is exercised and unvested shares repurchased. The Company reduced the liability and increased additional paid-in capital for the value of the note associated with vested shares no longer subject to the call right. During the nine months ended September 30, 2023, 8,375 shares of restricted common stock vested for a value of $10,302. As of September 30, 2023, the subscription receivable balance was $168,516 and the corresponding restricted stock award liability was $159,716.

As of September 30, 2023, inclusive of founders’ restricted stock issued in 2021, 3,185,037 shares of common stock had vested and 6,533,167 total shares of common stock were outstanding. Total issued shares of common stock were 6,860,053, which includes the shares of restricted stock issued with the recourse note.

During the nine months ended September 30, 2023 and 2022, the Company recorded stock-based compensation pertaining to vesting of restricted common stock of $218,453 and $72,300, respectively.

During the nine months ended September 30, 2023 and 2022, the Company repurchased restricted stock awards of 301,600 and 240,700 shares of common stock, respectively, for nominal value.

8.	STOCKHOLDERS’ EQUITY (DEFICIT)

Preferred Stock

The Company has issued Series Seed, Series Seed-1, Series Seed-2 and Series Seed-3 convertible preferred stock (collectively referred to as “Preferred Stock”). As of December 31, 2022, the Company’s certificate of incorporation, as amended and restated, authorized the Company to issue a total of 10,090,150 shares of Preferred Stock, of which 4,008,079 shares were designated as Series Seed Preferred Stock, 3,037,227 shares were designated as Series Seed-1 Preferred Stock, 2,599,497 shares were designated as Series Seed-2 Preferred Stock and 445,437 shares were designated as Series Seed-3 Preferred Stock.

The holders of the Preferred Stock have the following rights and preferences:

Voting

The holders of Preferred Stock are entitled to vote, together with the holders of common stock as a single class, on all matters submitted to stockholders for a vote and have the right to vote the number of shares equal to the number of shares of common stock into which each share of Preferred Stock could convert on the record date for determination of stockholders entitled to vote.

The Preferred Stock holders, voting together as a single class, shall be entitled to elect one director of the Company.

Dividends

The Company shall not declare, pay or set aside any dividends on shares of any class or series of capital stock of the Company unless the holders of Preferred Stock then outstanding shall first receive, or simultaneously receive, on a pari passu, equal priority basis a non-cumulative dividend on each outstanding share of each series of Preferred Stock in an amount to 8% of the Original Issue Price per share per annum for each series of Preferred Stock. The foregoing dividends shall not be cumulative and shall be paid, when, as and if declared by the Company’s board of directors. The Original Issue Price is (i) $3.8814 per share for the Series Seed Preferred Stock, (ii) $1.5161 per share for Series Seed-1 Preferred Stock, (iii) 2.7170 per share for Series Seed-2 Preferred Stock and (iv) $3.4932 per share for Series Seed-3 Preferred Stock. After payment to Preferred stockholders, any additional dividends shall be distributed among all holders of Common Stock and Preferred Stock in proportion to the number of shares of Common Stock that would be held if all holders of Preferred Stock were converted.

Liquidation

In the event of any voluntary or involuntary liquidation, dissolution or winding up of the Company or deemed liquidation event, the preferred stockholders, on a pari passu basis, shall be entitled to a liquidation preference equal to the greater of (i) the applicable Original Issuance Price applicable to each series, plus any dividends declared but unpaid on such share and (ii) such amount per share as would have been payable had all shares of such series of Preferred Stock been converted into Common Stock. After the payment of all preferential amounts to preferred stockholders, the remaining assets available for distribution shall be distributed among common stockholders on a pro-rata basis.

As of December 31, 2022 and 2021, the liquidation preferences were as follows:

	December 31,
	2022		2021
Series Seed preferred stock	$	11,999,997	$	10,999,998
Series Seed-1 preferred stock		3,699,950		3,699,950
Series Seed-2 preferred stock		5,674,962		5,674,962
Series Seed-3 preferred stock		1,250,000		1,250,000
	$	22,629,909	$	21,624,910

Conversion

Each share of Preferred Stock is convertible into common stock, at the option of the holder, at any time after the date of issuance. In addition, each share of Preferred Stock will be automatically converted into shares of common stock at the applicable conversion ratio then in effect (i) upon the closing of a firm-commitment public offering resulting in at least $50,000,000 of gross proceeds to the Company (or $11.6442 per share), subject to appropriate adjustment in the event of any stock dividend, stock split, combination or other similar recapitalization, or (ii) upon the written consent of the holders of a majority of the then-outstanding shares of Preferred Stock, voting together as a single class.

The conversion ratio of each series of Preferred Stock is determined by dividing the original issue price of each series by the conversion price of each series. The conversion price per share is (i) $3.8814 per share for the Series Seed Preferred Stock, (ii) $1.5161 per share for Series Seed-1 Preferred Stock, (iii) 2.7170 per share for Series Seed-2 Preferred Stock and (iv) $3.4932 per share for Series Seed-3 Preferred Stock, each subject to appropriate adjustment in the event of any stock dividend, stock split, combination or other similar recapitalization. Accordingly, as of December 31, 2022, each share outstanding of each series of Preferred Stock was convertible into shares of common stock on a one-for-one basis.

In the event that the Company issues additional securities at a purchase price less than the conversion price for a series of Preferred Stock, the conversion price shall be adjusted pursuant an anti-dilution formula defined in the certificate of incorporation, as amended and restated.

Transactions

In February 2022, the Company issued 257,639 shares of Series Seed Preferred Stock for gross proceeds of $999,999, or $3.8814 per share.

In October 2021, the Company issued 2,834,033 shares of Series Seed Preferred Stock for gross proceeds of $10,999,998, or $3.8814 per share.

See Note 7 for conversion of SAFEs into preferred stock.

Common Stock

After the Company’s amended to its certificate of incorporation in February 2022, the Company authorized 21,200,000 shares of common stock at $0.0001 par value as of December 31, 2022 (See Note 3 for presentation of authorized shares).

Common stockholders have voting rights of one vote per share and are entitled to elect two directors of the Company. The voting, dividend, and liquidation rights of the holders of common stock are subject to and qualified by the rights, powers, and preferences of preferred stockholders.

During the period ended December 31, 2021, the Company issued 3,535,400 shares of common stock to founders for proceeds of $4,400. Such are restricted and subject to vesting over four years.

Restricted Common Stock

During the period ended December 31, 2021, the Company issued 3,575,723 shares of restricted common stock, net of repurchases, for proceeds of $4,646. Of the restricted shares granted, 1,208,846 awards were originally subject to specified vesting milestones there were not expected to be met and therefore, no expense was recorded. In October 2022, the Company modified the milestone awards to eliminate the milestone requirements, to the extent they were still outstanding as of September 15, 2022. The shares became subject to time vesting, monthly over four years. Due to the modification, the Company recognized additional stock compensation of $137,196. The awards without milestones, vest monthly over time, generally over a four-year period with a one-year cliff.

During 2022, the Company issued 338,121 shares of restricted common stock for full recourse notes totaling $164,116. The shares were issued with a corresponding note receivable, a recourse loan that was collateralized by the underlying shares. The Company plans to enforce the recourse terms for the holders. As such, in accordance with ASC 505-10-45-2, the Company recognized a subscription receivable of $165,719, inclusive of interest on the note, which is included as a contra-equity on the consolidated balance sheets. The Company recorded a corresponding restricted stock award liability of $162,747 for the potential settlement if the call right for the shares of restricted common stock is exercised by the Company per the terms of the agreement, and unvested shares are repurchased. The Company reduced the liability and increased additional paid-in capital for the value of the note associated with vested shares no longer subject to the call right. In connection with this grant, the Company recognized stock compensation of $4,250.

As of December 31, 2022, inclusive of founders restricted stock described above, 2,354,466 shares of common stock had vested and 6,826,352 shares of common stock were outstanding. Total issued shares of common stock totaled 7,161,654, which includes the shares of restricted stock issued with the recourse note.

During the years ended December 31, 2022 and 2021, the Company recorded stock-based compensation pertaining to vesting of restricted common stock of $141,446 and $0, respectively.

During 2022, the Company repurchased restricted stock awards of 287,591 shares of common stock for nominal value.

Patricia Acquisition Corp.[Member]

Stockholders' Equity [Line Items]

STOCKHOLDERS’ EQUITY

Note 3. Capital Stock

Preferred Stock

As of June 30, 2023 and December 31, 2022, the Company has 10,000,000 shares of preferred stock, par value of $0.0001, authorized and none issued or outstanding.

Common Stock

As of June 30, 2023 and December 31, 2022, the Company has 50,000,000 shares of common stock, par value of $0.0001, authorized and has 5,000,000 shares issued and outstanding.

Note 3. Capital Stock

Preferred Stock

As of December 31, 2022 and 2021, the Company has 10,000,000 shares of preferred stock, par value of $0.0001, authorized and none issued or outstanding.

Common Stock

As of December 31, 2022 and 2021, the Company has 50,000,000 shares of common stock, par value of $0.0001, authorized and has issued 5,000,000 shares of its $0.0001 par value common stock for $500 to the founders of the Company.

- Definition

The entire disclosure for equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-13

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-13

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-14

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 235
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481062/946-235-50-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 235
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481062/946-235-50-2

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 505
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481004/946-505-50-6

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480237/815-40-50-6

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(e)(1))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 505
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org//505/tableOfContent

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-13

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-13

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-13

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-14

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-14

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 16
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-16

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-18

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-18

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-18

+ Details

Reverse Merger Accounting

9 Months Ended

Sep. 30, 2023

Reverse Merger Accounting [Abstract]

REVERSE MERGER ACCOUNTING

3. REVERSE MERGER ACCOUNTING

On July 31, 2023, Acquisition Sub, merged with and into the Company. Pursuant to the Merger, the Company was the surviving corporation and became Patricia’s wholly owned subsidiary, and all of the outstanding stock of Serve was converted into shares of Patricia’s common stock. All of Serve’s outstanding warrants and options were assumed by Patricia. Following the consummation of the Merger, Serve changed its name to “Serve Operating Co.”

The merger was accounted for as a reverse-merger, and recapitalization in accordance with generally accepted accounting principles in the United States (“GAAP”). Serve Robotics Inc. was the acquirer for financial reporting purposes and the Company was the acquired company. Consequently, the assets and liabilities and the operations that are reflected in the historical financial statements prior to the merger are those of Serve Robotics Inc. and have been recorded at the historical cost basis of Serve Robotics Inc., and the financial statements after completion of the merger include the assets and liabilities of the Company and Serve Robotics Inc., historical operations of Serve Robotics Inc. and operations of the Company from the closing date of the merger. Common stock and the corresponding capital amounts of the Company pre-merger were retroactively restated as capital stock shares reflecting the exchange ratio in the merger. In conjunction with the merger, the Company received no cash and assumed no liabilities from Patricia Acquisition Corp.

Fair Value Measurements (Details) - Schedule of Changes in Fair Value - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]
Beginning	$ 13,150,745
Issuance of simple agreements for future equity	2,666,953
Issuance of embedded derivative liability	601,000
Change in fair value	1,821,706
Conversion to common stock before APO	(18,240,404)
Ending		$ 13,150,745
Simple Agreement for Future Equity [Member]
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]
Beginning	13,150,745
Issuance of simple agreements for future equity	2,666,953	12,885,001	7,925,000
Issuance of embedded derivative liability
Change in fair value	1,672,706	265,744	11,043,155
Conversion to common stock before APO	(17,490,404)
Ending		13,150,745
Embedded Derivative Liability [Member]
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]
Beginning
Issuance of simple agreements for future equity
Issuance of embedded derivative liability	601,000
Change in fair value	149,000
Conversion to common stock before APO	(750,000)
Ending

Stockholders' Equity (Details) - Schedule of Liquidation - Previously Reported [Member] - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Stockholders' Equity (Details) - Schedule of Liquidation [Line Items]
Liquidation preference preferred stock	$ 22,629,909	$ 21,624,910
Series Seed preferred stock [Member]
Stockholders' Equity (Details) - Schedule of Liquidation [Line Items]
Liquidation preference preferred stock	11,999,997	10,999,998
Series Seed-1 preferred stock [Member]
Stockholders' Equity (Details) - Schedule of Liquidation [Line Items]
Liquidation preference preferred stock	3,699,950	3,699,950
Series Seed-2 preferred stock [Member]
Stockholders' Equity (Details) - Schedule of Liquidation [Line Items]
Liquidation preference preferred stock	5,674,962	5,674,962
Series Seed-3 preferred stock [Member]
Stockholders' Equity (Details) - Schedule of Liquidation [Line Items]
Liquidation preference preferred stock	$ 1,250,000	$ 1,250,000

Summary of Significant Accounting Policies

6 Months Ended

9 Months Ended

12 Months Ended

Jun. 30, 2023

Sep. 30, 2023

Dec. 31, 2022

Summary of Significant Accounting Policies [Line Items]

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

4 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accounting and reporting policies of the Company conform to GAAP. The Company’s fiscal year is December 31.

Capital Stock Conversion

Principles of Consolidation

Unaudited Interim Financial Information

Use of Estimates

Concentrations of Credit Risk

Concentrations

During the nine months ended September 30, 2023, one customer accounted for 68% of revenue.

Cash and Cash Equivalents

The Company considers all highly liquid investments with maturities of three months or less at the date of purchase to be cash equivalents.

Fair Value Measurements

●

Level 1—Quoted prices in active markets for identical assets or liabilities.

●

See Notes 4 and 7 for fair value disclosures of future equity obligations.

Accounts Receivable

Inventory

Property and Equipment

Impairment of Long-Lived Assets

Deferred Offering Costs

Convertible Instruments

Subscription Receivable

Revenue Recognition

The Company accounts for revenue under ASC 606, Revenue from Contracts with Customers. The Company determines revenue recognition through the following steps:

	●	Identification of a contract with a customer;

	●	Identification of the performance obligations in the contract;

	●	Determination of the transaction price;

	●	Allocation of the transaction price to the performance obligations in the contract; and

●

Recognition of revenue when or as the performance obligations are satisfied.

Cost of Revenue

Sales and Marketing

Operations

Operations expenses primarily consist of costs for field operations personnel.

General and Administrative Expenses

Research and Development Costs

Costs incurred in the research and development of the Company’s products are expensed as incurred. Research and development costs include product design, hardware and software costs.

Leases

(i)

there is an identified asset

(ii)

the Company obtains substantially all of the economic benefits of the asset

(iii)

the Company has the right to direct the use of the asset

Net Loss per Share

	September 30,
	2023		2022
Series Seed preferred stock (convertible to common stock)		-		3,091,672
Series Seed-1 preferred stock (convertible to common stock)		-		2,440,412
Series Seed-2 preferred stock (convertible to common stock)		-		2,088,696
Series Seed-3 preferred stock (convertible to common stock)		-		357,836
Common stock warrants		142,730		54,203
Preferred stock warrants		-		128,819
Stock options		1,594,800		941,406
Unvested restricted common stock issued not outstanding		326,839		-
Total potentially dilutive shares		2,064,369		9,103,044

Recently Adopted Accounting Pronouncements

3.	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accounting and reporting policies of the Company conform to accounting principles generally accepted in the United States of America (“GAAP”). The Company’s fiscal year is December 31.

Reverse Merger and Recapitalization

Unaudited Pro Forma Financial Information

At the Closing of the Merger described above, all outstanding shares of the Series Seed Preferred Stock were converted into shares of common stock.

	December 31, 2022
	Actual			Pro Forma
Stockholders’ deficit:				(unaudited)
Series Seed preferred stock	$	309		$	-
Series Seed-1 preferred stock		244			-
Series Seed-2 preferred stock		209			-
Series Seed-3 preferred stock		36			-
Common stock		683			1,481
Additional paid-in capital		31,232,737			31,232,737
Subscription receivable		(165,719	)		(165,719	)
Accumulated deficit		(43,520,645	)		(43,520,645	)
Total stockholders’ deficit	$	(12,452,146	)	$	(12,452,146	)

Principles of Consolidation

Use of Estimates

Concentrations of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents. The Company generally maintains balances in various operating accounts at financial institutions that management believes to be of high credit quality, in amounts that may exceed federally insured limits. The Company has not experienced any losses related to its cash and cash equivalents and does not believe that it is subject to unusual credit risk beyond the normal credit risk associated with commercial banking relationships. At December 31, 2022 and 2021, all of the Company’s cash and cash equivalents were held at one accredited financial institution. As of December 31, 2022 and 2021, the Company had $2,465,719 and $7,715,861, respectively, in excess of insured amounts.

Cash and Cash Equivalents

The Company considers all highly liquid investments with maturities of three months or less at the date of purchase to be cash equivalents.

Fair Value Measurements

●

Level 1—Quoted prices in active markets for identical assets or liabilities.

●

The carrying values of the Company’s assets and liabilities approximate their fair values.

See Note 4 for fair value measurement disclosures.

Accounts Receivable

Inventory

Property and Equipment

Property and equipment are stated at cost less accumulated depreciation. Depreciation expense is recognized using the straight-line method over the estimated useful life of the asset, which is three (3) to five (5) years for office equipment and two (2) years for the Company’s current robot assets. Estimated useful lives are periodically assessed to determine if changes are appropriate. Maintenance and repairs are charged to expense as incurred. When assets are retired or otherwise disposed of, the cost of these assets and related accumulated depreciation or amortization are eliminated from the balance sheets and any resulting gains or losses are included in the statement of operations in the period of disposal.

Impairment of Long-Lived Assets

Revenue Recognition

The Company accounts for revenue in accordance with ASC 606 – Revenue from Contracts with Customers ( “ASC 606”). The Company determines revenue recognition through the following steps:

	●	Identification of a contract with a customer;

	●	Identification of the performance obligations in the contract;

	●	Determination of the transaction price;

	●	Allocation of the transaction price to the performance obligations in the contract; and

●

Recognition of revenue when or as the performance obligations are satisfied.

During the year ended December 31, 2022, delivery revenue was $54,423 and branding fees were $53,575, respectively.

Cost of Revenue

Sales and Marketing

Sales and marketing expenses includes personnel costs and public relations expenses. Advertising costs are expensed as incurred and included in sales and marketing expense.

Operations

Operations expenses primarily consists of costs for field operations personnel that support operations in cities, including supervisors and related costs.

General and Administrative Expenses

General and administrative expenses primarily consist of personnel-related expenses for executive management and administrative functions, including finance and accounting, legal, and human resources, as well as general corporate expenses and general insurance. General and administrative expenses also include depreciation on certain property and equipment as well as amortization of allocated portions of right of use assets. These costs are expensed as incurred.

Research and Development Costs

Costs incurred in the research and development of the Company’s products are expensed as incurred. Research and development costs include product design, hardware and software costs.

Concentrations

Accounting for Preferred Stock

Stock-Based Compensation

Leases

In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) 2016 02, Leases (ASC 842). This ASU requires a lessee to recognize a right-of-use asset and a lease liability under most operating leases in its balance sheet. The ASU is effective for annual and interim periods beginning after December 15, 2021. Early adoption is permitted. The Company adopted ASC 842 on January 1, 2022 using the modified retrospective approach. The Company elected the package of practical expedients available for existing contracts, which allowed the Company to carry forward our historical assessments of lease identification, lease classification, and initial direct costs. The Company also elected a policy to not apply the recognition requirements of ASC 842 for short-term leases with a term of 12 months or less.

(i)

there is an identified asset

(ii)

the Company obtains substantially all of the economic benefits of the asset

(iii)

the Company has the right to direct the use of the asset

Income Taxes

Net Loss per Share

Net earnings or loss per share is computed by dividing net income or loss by the weighted-average number of common shares outstanding during the period, excluding shares subject to redemption or forfeiture. The Company presents basic and diluted net earnings or loss per share. Diluted net earnings or loss per share reflect the actual weighted average of common shares issued and outstanding during the period, adjusted for potentially dilutive securities outstanding. Potentially dilutive securities are excluded from the computation of the diluted net loss per share if their inclusion would be anti-dilutive. As all potentially dilutive securities are anti-dilutive as of December 31, 2022 and 2021, diluted net loss per share is the same as basic net loss per share for each period. Potentially dilutive items outstanding as of December 31, 2022 and 2021 is as follows:

	December 31,
	2022		2021
Series Seed preferred stock (convertible to common stock)		3,091,672		2,834,033
Series Seed-1 preferred stock (convertible to common stock)		2,440,411		2,440,411
Series Seed-2 preferred stock (convertible to common stock)		2,088,696		2,088,696
Series Seed-3 preferred stock (convertible to common stock)		357,836		357,836
Common stock warrants		54,203		13,912
Preferred stock warrants		128,819		128,819
Stock options		861,309		590,073
Total potentially dilutive shares		9,022,946		8,453,780

Recently Adopted Accounting Pronouncements

Patricia Acquisition Corp.[Member]

Summary of Significant Accounting Policies [Line Items]

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Note 2. Basis of Presentation and Summary of Significant Accounting Policies

Basis of Presentation

Use of Estimates

Income Taxes

Net Loss per Common Share

Emerging Growth Company

Recently Issued Accounting Pronouncements

Management does not believe that any recently issued, but not yet effective accounting pronouncements, if adopted, would have a material effect on the accompanying financial statements.

Note 2. Basis of Presentation and Summary of Significant Accounting Policies

Basis of Presentation

The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”).

Use of Estimates

Income Taxes

The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2022 and 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

Net Loss per Common Share

Net loss per share is computed by dividing net loss by the weighted average number of common shares outstanding for the period. Diluted earnings per share takes into effect any dilutive instruments, except when doing so would be anti-dilutive. As of December 31, 2022 and 2021, there were no dilutive instruments.

Emerging Growth Company

Recently Issued Accounting Pronouncements

Management does not believe that any recently issued, but not yet effective accounting pronouncements, if adopted, would have a material effect on the accompanying financial statements.

Property and Equipment, net (Details) - USD ($)	9 Months Ended		12 Months Ended
Property and Equipment, net (Details) - USD ($)	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2021	Nov. 30, 2022
Property and Equipment, net (Details) [Line Items]
Capitalized Computer Software, Net						$ 3,561,288
Depreciation expense	$ 1,396,919	$ 40,521	$ 388,139		$ 42,469
Previously Reported [Member]
Property and Equipment, net (Details) [Line Items]
Depreciation expense			$ 388,139	$ 42,469

Commitments and Contingencies (Details) - Schedule of Maturities of Lease Liabilities	Dec. 31, 2022 USD ($)
Commitments and Contingencies (Details) - Schedule of Maturities of Lease Liabilities [Line Items]
2023	$ 483,186
2024	527,983
2025	214,776
Total lease payments	1,225,945
Less: imputed interest	(34,616)
Total lease obligations	$ 1,191,329

Document And Entity Information	9 Months Ended
Document And Entity Information	Sep. 30, 2023
Document Information Line Items
Entity Registrant Name	Serve Robotics Inc.
Document Type	S-1/A
Amendment Flag	true
Amendment Description	AMENDMENT NO. 2
Entity Central Index Key	0001832483
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Incorporation, State or Country Code	DE

Commitments and Contingencies (Details) - Schedule of Supplemental Cash Flow - USD ($)	9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021
Schedule of Supplemental Cash Flow [Abstract]
Operating cash flows paid for operating leases	$ 411,393	$ 252,997	$ 381,457
Right-of-use assets obtained in exchange for operating lease obligations		$ 1,535,230	$ 1,535,230

Income Taxes (Tables)

6 Months Ended

12 Months Ended

Jun. 30, 2023

Dec. 31, 2022

Income Taxes (Tables) [Line Items]

Schedule of Deferred Tax Assets and Liabilities [Table Text Block]

The following table presents the deferred tax assets and liabilities by source:

	December 31,
	2022			2021
Deferred tax assets:
Net operating loss carryforwards	$	8,940,441		$	2,982,757
Other temporary differences		85,998			-
Valuation allowance		(9,026,439	)		(2,982,757	)
Net deferred tax assets	$	-		$	-

Patricia Acquisition Corp.[Member]

Income Taxes (Tables) [Line Items]

Schedule of Statutory Federal Income Tax Rate

	June 30, 2023			December 31, 2022
Statutory federal income taxes		21.0	%		21.0	%
Valuation allowance		(21.0	)%		(21.0	)%
Effective income tax rate, net		-	%		-	%

The difference between the tax provision at the statutory federal income tax rate on December 31, 2022 and 2021 and the tax provisions attributable to loss before income taxes is as follows:

	December 31,
	2022			2021
Statutory federal income taxes		21.0	%		21.0	%
Valuation allowance		(21.0	)%		(21.0	)%
Effective income tax rate, net		-			-

Property and Equipment, net (Details) - Schedule of Property and Equipment, Net - USD ($)	Sep. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Property, Plant and Equipment [Line Items]
Property and equipment	$ 3,809,528	$ 3,807,035	$ 162,085
Less: accumulated depreciation	(1,827,527)	(430,608)	(42,469)
Property and equipment, net	1,982,001	3,376,427	119,616
Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment	248,240	245,747	$ 162,085
Robot assets [Member]
Property, Plant and Equipment [Line Items]
Property and equipment	$ 3,561,288	$ 3,561,288

Subsequent Events

6 Months Ended

9 Months Ended

12 Months Ended

Jun. 30, 2023

Sep. 30, 2023

Dec. 31, 2022

Subsequent Events [Line Items]

SUBSEQUENT EVENTS

11. SUBSEQUENT EVENTS

Private Placement

On October 26, 2023, the Company completed a subsequent closing of the Private Placement and issued 143,531 shares of common stock for gross proceeds of $547,127, or $4.00 per share. The Company received $529,127 in net proceeds.

Management has evaluated subsequent events through November 14, 2023, the date the condensed financial statements were available to be issued. Based on this evaluation, no material events were identified which require adjustment or disclosure in these condensed financial statements.

12.

SUBSEQUENT EVENTS

Management has evaluated subsequent events through May 19, 2023, the date the financial statements were available to be issued. Based on this evaluation, no additional material events were identified which require adjustment or disclosure in these financial statements.

In April 2023, the Company received bridge financing totaling $3,000,000 in principal, due in six months from the note date. The bridge financing bear interest at 10% per annum and are payable six months from the date of the bridge financing, subject to conversion. Upon the Company’s planned reverse merger (“PIPE Offering”), the note will convert into shares of common stock at a conversion price equal to 80% of the price per the PIPE offering. Th note is secured by the assets of the Company, and subordinated to the Company’s Silicon Valley Bank loan.

In connection with the bridge financing, the Company granted the lender warrants to purchase common stock equal to 50% of the number of shares of common stock into which the loan is convertible into.

Through the issuance date, the Company has received proceeds from SAFEs totaling $2,666,953 with similar terms to the SAFEs in Note 7.

Patricia Acquisition Corp.[Member]

Subsequent Events [Line Items]

SUBSEQUENT EVENTS

Note 7. Subsequent Events

The Company evaluated subsequent events and transactions that occurred up to the date the condensed financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the condensed financial statements, except as disclosed below.

On July 31, 2023, the Company consummated the previously announced merger by and among the Company, a recently formed wholly-owned subsidiary of the Company (“Merger Sub”), and Serve Robotics Inc, a privately held Delaware corporation (“Serve”), pursuant to which Merger Sub would merge with and into Serve, with Serve continuing as the surviving entity (the “Merger”) and as the Company’s wholly-owned subsidiary, after which the Company would continue the business of Serve. The Merger occurred pursuant to that certain Agreement and Plan of Merger (the “Merger Agreement”) by and among the Company, Serve, and Merger Sub.

Serve is an autonomous sidewalk delivery company. The company designs, develops and operates low-emission robots that serve people in public spaces, starting with food delivery. Serve is headquartered in Redwood City, California.

Pursuant to the terms of the Merger Agreement, all outstanding equity interests of Serve converted into shares of our Common Stock, such that the holders of Serve equity before the Merger own a majority of the outstanding shares of our Common Stock after the Merger (before giving effect to a private placement offering of Common Stock by the Company that was consummated in connection with the Merger), resulting in a change of control of the Company.

Certain other information regarding the Merger and changes to the management and share ownership of the Company is set forth in the Current Report on Form 8-K filed by the Company with the SEC on August 4, 2023, as amended (the “Super 8-K”).

The foregoing description of the Merger Agreement and Common Stock private placement and related matters does not purport to be complete and is qualified in its entirety by the terms of the actual Merger Agreement and of terms and documentation for a private placement, which are filed with the SEC as exhibits to the Super 8-K.

Income Taxes (Details) - Schedule of Statutory Federal Income Tax Rate - Patricia Acquisition Corp.[Member]	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Investments, Owned, Federal Income Tax Note [Line Items]
Statutory federal income taxes	21.00%	21.00%	21.00%
Valuation allowance	(21.00%)	(21.00%)	(21.00%)
Effective income tax rate, net

Income Taxes (Details) - Schedule of Statutory Federal Income Tax Rate - Patricia Acquisition Corp.[Member]	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Investments, Owned, Federal Income Tax Note [Line Items]
Statutory federal income taxes	21.00%	21.00%	21.00%
Valuation allowance	(21.00%)	(21.00%)	(21.00%)
Effective income tax rate, net

Summary of Significant Accounting Policies (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Nature of Operations [Abstract]

Schedule of Business Combination are Excluded from such Pro-Forma

The shares of common stock issuable and the proceeds expected to be received in the Business Combination are excluded from such pro-forma financial information.

	December 31, 2022
	Actual			Pro Forma
Stockholders’ deficit:				(unaudited)
Series Seed preferred stock	$	309		$	-
Series Seed-1 preferred stock		244			-
Series Seed-2 preferred stock		209			-
Series Seed-3 preferred stock		36			-
Common stock		683			1,481
Additional paid-in capital		31,232,737			31,232,737
Subscription receivable		(165,719	)		(165,719	)
Accumulated deficit		(43,520,645	)		(43,520,645	)
Total stockholders’ deficit	$	(12,452,146	)	$	(12,452,146	)

Schedule of Potentially Dilutive Items Outstanding

As all potentially dilutive securities are anti-dilutive as of September 30, 2023 and December 31, 2022, diluted net loss per share is the same as basic net loss per share for each period. Potentially dilutive items outstanding as of September 30, 2023 and 2022 is as follows:

	September 30,
	2023		2022
Series Seed preferred stock (convertible to common stock)		-		3,091,672
Series Seed-1 preferred stock (convertible to common stock)		-		2,440,412
Series Seed-2 preferred stock (convertible to common stock)		-		2,088,696
Series Seed-3 preferred stock (convertible to common stock)		-		357,836
Common stock warrants		142,730		54,203
Preferred stock warrants		-		128,819
Stock options		1,594,800		941,406
Unvested restricted common stock issued not outstanding		326,839		-
Total potentially dilutive shares		2,064,369		9,103,044

Potentially dilutive items outstanding as of December 31, 2022 and 2021 is as follows:

	December 31,
	2022		2021
Series Seed preferred stock (convertible to common stock)		3,091,672		2,834,033
Series Seed-1 preferred stock (convertible to common stock)		2,440,411		2,440,411
Series Seed-2 preferred stock (convertible to common stock)		2,088,696		2,088,696
Series Seed-3 preferred stock (convertible to common stock)		357,836		357,836
Common stock warrants		54,203		13,912
Preferred stock warrants		128,819		128,819
Stock options		861,309		590,073
Total potentially dilutive shares		9,022,946		8,453,780

Note Payable (Details) - Schedule of Future Principal Payments Owed	Dec. 31, 2022 USD ($)
Note Payable (Details) - Schedule of Future Principal Payments Owed [Line Items]
2023	$ 1,000,000
2024	1,000,000
2025	250,000
Principal payments	$ 2,250,000

- Definition

Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.

+ References + Details

Income Taxes (Details) - Schedule of Deferred Taxes Assets and Liabilities - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Deferred tax assets:
Net operating loss carryforwards	$ 8,940,441	$ 2,982,757
Other temporary differences	85,998
Valuation allowance	(9,026,439)	(2,982,757)
Net deferred tax assets

Stockholders’ Equity (Details) - Schedule of Liquidation Preferences - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Stockholders’ Equity (Details) - Schedule of Liquidation Preferences [Line Items]
Liquidation preference preferred stock		$ 22,624,909
Series Seed preferred stock [Member]
Stockholders’ Equity (Details) - Schedule of Liquidation Preferences [Line Items]
Liquidation preference preferred stock		11,999,997
Series Seed-1 preferred stock [Member]
Stockholders’ Equity (Details) - Schedule of Liquidation Preferences [Line Items]
Liquidation preference preferred stock		3,699,950
Series Seed-2 preferred stock [Member]
Stockholders’ Equity (Details) - Schedule of Liquidation Preferences [Line Items]
Liquidation preference preferred stock		5,674,962
Series Seed-3 preferred stock [Member]
Stockholders’ Equity (Details) - Schedule of Liquidation Preferences [Line Items]
Liquidation preference preferred stock		$ 1,250,000

Unaudited Condensed Consolidated Statements of Operations - USD ($)	3 Months Ended				6 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2023	Jun. 30, 2023	Sep. 30, 2022	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2021
Revenues	$ 62,565		$ 33,333				$ 164,826	$ 60,689	$ 107,819
Cost of revenues	572,537		341,517				1,331,165	721,198	1,148,426
Gross loss	(509,972)		(308,184)				(1,166,339)	(660,509)	(1,040,607)
Operating expenses:
General and administrative	1,428,143		952,553				3,414,949	2,666,005	3,786,124		2,465,570
Operations	558,068		681,434				1,672,403	1,555,841	2,035,063		924,501
Research and development	2,962,812		3,261,785				7,171,446	9,275,252	13,565,765		7,092,628
Sales and marketing	118,793		120,537				481,511	398,635	525,494		139,664
Total operating expenses	5,067,816		5,016,309				12,740,309	13,895,733	19,912,446		10,622,363
Loss from operations	(5,577,788)		(5,324,493)				(13,906,648)	(14,556,242)	(20,953,053)		(10,622,363)
Other income (expense), net:
Interest expense, net	(1,483,390)		(34,112)				(2,021,996)	(49,028)	(636,330)
Change in fair value of derivative liability	(149,000)						(149,000)		(265,744)		(11,043,155)
Change in fair value of simple agreements for future equity	(435,794)						(1,672,706)	4,506
Total other income (expense), net	(2,068,184)		(34,112)				(3,843,702)	(44,522)	(902,074)		(11,043,155)
Provision for income taxes
Net loss	$ (7,645,972)	$ (4,966,256)	$ (5,358,605)	$ (5,300,015)			$ (17,750,350)	$ (14,600,764)	$ (21,855,127)		$ (21,665,518)
Weighted average common shares outstanding - basic and diluted (in Shares)	18,528,262		6,871,200				10,674,991	6,990,773	6,896,769		5,622,548
Net loss per common share - basic and diluted (in Dollars per share)	$ (0.41)		$ (0.78)				$ (1.66)	$ (2.09)	$ (3.17)		$ (3.85)
Patricia Acquisition Corp.
Revenues
Operating expenses:
General and administrative		17,839		19,190	29,321	27,078			51,354	54,627
Loss from operations		(17,839)		(19,190)	(29,321)	(27,078)			(51,354)	(54,627)
Other income (expense), net:
Net loss		$ (17,839)		$ (19,190)	$ (29,321)	$ (27,078)			$ (51,354)	$ (54,627)
Weighted average common shares outstanding - basic and diluted (in Shares)		5,000,000		5,000,000	5,000,000	5,000,000			5,000,000	5,000,000
Net loss per common share - basic and diluted (in Dollars per share)		$ 0		$ 0	$ (0.01)	$ (0.01)			$ (0.01)	$ (0.01)

Stock-Based Compensation (Details) - Schedule of Stock-Based Compensation Expense - Stock Options [Member] - USD ($)	9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021
Stock-Based Compensation (Details) - Schedule of Stock-Based Compensation Expense [Line Items]
General and administrative	$ 33,239	$ 12,527
Operations	27,902	7,662	$ 14,625
Research and development	232,182	91,552	152,739
Sales and marketing	10,933	2,065	4,042
Stock-based compensation expense	$ 304,256	$ 113,806	$ 195,056	$ 8,714